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INTRODUCTION
Advances in gastrointestinal (GI) endoscopy have played an important role in improving 
the diagnostic and therapeutic options for physicians treating patients with GI diseases. 
Indeed, the advent of endoscopy transformed the field of Gastroenterology and con-
tributed significantly to its emergence as a specialty separate from Internal Medicine 
and General Surgery. As the pace of technological progress has quickened, innovation 
in GI endoscopy has only accelerated, expanding the tools available to the practicing 
gastroenterologist. However, it remains essential that physicians examine technology 
with a critical eye to ensure that new devices or techniques are truly an improvement for 
patient care, both in terms of efficacy and safety. In addition, it is important that existing 
practices are frequently examined and critically reevaluated in order to deliver clinical 
care at the highest level of quality. For this reason, clinical research is a necessary com-
ponent of the modern practice of medicine, a maxim that holds true for GI endoscopy as 
much as for any other field.
The practice of endoscopy can be traced back to the development of an early gastro-
scope by Rudolf Schindler and George Wolf of Germany in the early 1920’s.1 However, 
this device relied on a series of optical lenses and prisms that made it rather cumber-
some to use. It wasn’t until the innovation of fiberoptics, bundles of fine glass fibers 
capable of conducting light over distances, that flexible endoscopy became a clinically 
useful proposition.2 Basil Hirschowitz was a major pioneer in this area and introduced 
the first fully flexible gastroscope to the world in the 1950’s.3 These advances were then 
incorporated into lower GI endoscopy in the form of the first flexible sigmoidoscope by 
Bergein Overholt in 1963.4 Soon thereafter, longer versions were developed into colo-
noscopes and by the 1970’s, colonoscopy was being rapidly adopted by gastroenterolo-
gists. The 1970’s also heralded the advent of biliary endoscopy, first in Japan and then 
most prominently by Peter Cotton in Britain who coined the term endoscopic retrograde 
cholangiopancreatography (ERCP).5 In the ensuing decades, GI endoscopy in the form 
of gastroscopy, colonoscopy and ERCP became cornerstones in the practice of gastro-
enterology. The field has been further expanded by the development of endoscopic 
ultrasound (EUS),6 which enables ultrasound images to be obtained from within the 
lumen of the GI tract, and most recently by small bowel endoscopy,7,8 which has placed 
the small intestine within the diagnostic and therapeutic reach of gastroenterologists.
This paper will focus on innovation and best practices in endoscopy, first with respect to 
colonoscopy, and second in regards to small bowel endoscopy.
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Colonoscopy
In current practice, one of the most common reasons that patients undergo colonoscopy 
is colon cancer screening and polyp surveillance. Indeed, colonoscopy is the preferred 
colon cancer screening modality by the American College of Gastroenterology9 and 
the American Gastroenterological Association.10 This is important because colorectal 
cancer (CRC) is a leading cause of cancer-related morbidity and mortality.11 In the vast 
majority of cases, colon cancers develop from a prolonged adenoma-to-carcinoma 
sequence, which given sufficient time and accumulation of enough genetic mutations, 
enable polyps to transform and grow into cancer.12 Considerable efforts within the field 
of Gastroenterology have been devoted to the use of colonoscopy for the detection 
and removal of potentially pre-cancerous polyps, with the aim of preventing colon 
cancer, and for the diagnosis of early stage disease that is more likely to be treatable 
and result in long-term survival. Indeed, colonoscopy has been shown to decrease the 
likelihood of developing colon cancer as well as CRC-related mortality.12-15 However, re-
cent evidence suggests that colonoscopy has not been as universally protective against 
CRC as had been previously hoped, particularly for proximal cancers located in the right 
colon.16,17 Theories as to why this might be the case include speculation about altered 
biology of cancers that develop in the proximal colon and technical issues relating to 
the performance of colonoscopy itself.18 In particular, one of the problems is incomplete 
colonoscopy that fails to examine the entire colon to the cecum, which may occur in 
more than 10-20% of cases.19,20 Furthermore, wide variability in detection rates of neo-
plastic lesions, with inadequately low rates by many practitioners, demonstrates that 
colonoscopy technique plays an important role in the cancer prevention properties of 
the test.21 In particular, longer colonoscope withdrawal times have been clearly linked 
to significantly greater adenoma detection rates and to an increased mean number of 
polyps detected per patient, with a minimum withdrawal time of 6 minutes established 
as a necessary threshold.22 In addition, from a public health standpoint, a considerable 
proportion of the population remain averse to undergoing colonoscopy, particularly 
because of fears of procedure discomfort,23,24 decreasing the potential impact for overall 
CRC reduction. Thus, optimizing the technical performance of colonoscopy and improv-
ing its acceptance among patients is important for maximizing the possible benefits to 
society.
The most common reasons for a technically challenging colonoscopy include a nar-
rowed, angulated sigmoid colon and a long, redundant colon in which the endoscopist 
“runs out of scope” before reaching the cecum,25 of which the latter is usually due to 
excessive looping of the endoscope. Furthermore, while the physiology of pain expe-
rienced during colonoscopy is caused by stretching of the mesentery attached to the 
bowel, a study with “on demand” patient-controlled analgesia showed that 79% of pain-
1
Introduction and outline of thesis 11
ful episodes were caused by endoscope looping, primarily when the scope tip was in 
the sigmoid colon.26 Experts agree that colonoscopy is most successful at reaching the 
cecum and most comfortable for patients when the endoscope is kept in a straight posi-
tion by minimizing loop formation and reducing loops once they have formed.25,27 Thus, 
identification and reduction of endoscope loops is critically important for the successful 
and comfortable completion of colonoscopy. Over the years, many techniques have 
emerged to overcome loop formation and assist the performance of colonoscopy, in-
cluding withdrawal of the endoscope with torque, abdominal wall pressure and patient 
position changes. A study that examined colonoscopy while using external magnetic 
imaging identified loop formation in 91% of cases, but found that conventional maneu-
vers to overcome loops such as abdominal compression and position changes were only 
successful in 52% of attempts.28 This is not surprising given that 69% of loops were incor-
rectly diagnosed, an important consideration given that understanding of loop shape 
is necessary to determine the type of maneuver needed to overcome it. Despite these 
limitations, these maneuvers form the cornerstones of current colonoscopy technique. 
Technological innovations such as smaller caliber “pediatric” colonoscopes and “variable 
stiffness” colonoscopes with adjustable rigidity have been introduced that have had 
moderate success in diminishing patient discomfort, reducing sedation requirements 
and increasing rates of cecal intubation.29-32 Yet despite these efforts to improve colo-
noscopy practice, the reality is that many procedures are still done poorly. An audit of 
all colonoscopies performed in Winnipeg, Manitoba from 2004 to 2006 demonstrated a 
dismal completion rate of only 65%.33 Thus, greater improvements are clearly needed to 
bring the performance of colonoscopy up to an excellent standard.
Part of achieving high standards in the delivery of colonoscopy requires that endocopists 
receive sufficient training to ensure that they possess the necessary skills to reach 
those targets. Unfortunately, a clear consensus is lacking as to the nature and extent 
of training required to accomplish these aims, and whether additional measures are 
necessary to ensure ongoing quality and competency in endoscopy for those already 
in clinical practice. While the skillset necessary to effectively perform colonoscopy has 
been clearly defined by the American Society of Gastrointestinal Endoscopy (ASGE),34 
there are discrepancies regarding the minimum number of procedures required to meet 
the threshold for competency, with the traditional ASGE guideline of 140 procedures 
differing significantly from the 50 procedures mandated by general surgery and family 
medicine societies.35 Furthermore, a substantial learning curve has been demonstrated 
that suggests a far higher minimum threshold of 275 procedures is needed to achieve 
a reasonable standard of quality metrics.36 Thus, the true training needs of colonoscopy 
learners remains uncertain. Recently, attention has turned to incorporating technologi-
cal innovations such as computerized endoscopy simulation37,38 and magnetic imaging 
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systems39 to facilitate the learning process, particularly at earlier stages of training. 
Whether this will translate into improved performance of colonoscopy in subsequent 
clinical practice has yet to be determined.
Small Bowel Endoscopy
For several decades after the widespread adoption of gastroscopy and colonoscopy into 
clinical practice, the small intestine remained a “black box” that was for the most part 
inaccessible to endoscopists. Access to the small bowel was either limited in scope (push 
enteroscopy), highly invasive (intra-operative enteroscopy) or consisted of relatively 
crude radiologic studies (small bowel barium X-ray and enteroclysis). This all changed 
with two dramatic technological innovations that occurred at the start of the last de-
cade. Capsule endoscopy (CE) was approved for use in Europe and the United States 
in 20017 and later in Japan in 2007, and has quickly become part of standard-of-care in 
the investigation of small bowel diseases.40 Around the same time, Hironori Yamamoto 
introduced double balloon endoscopy (DBE) as the first type of overtube-assisted de-
vice that enabled direct endoscopic access to the entire GI tract.41 Together, CE and DBE 
have revolutionized the approach to small bowel diseases in general and to obscure GI 
bleeding in particular.
CE consists of a pill camera that is swallowed by the patient and then moves passively 
through the GI tract by persistalsis, taking thousands of images that are wirelessly trans-
mitted by radio waves to sensors placed on the patient’s abdomen, which are themselves 
connected to a special data recorder.42 Once the study is completed, the data recorder 
is docked to a computer workstation and the endoscopic images are reformatted into 
a video file that can then be viewed for analysis. CE is appealing for patients since it 
is relatively non-invasive and is performed in an outpatient setting with virtually no 
discomfort, and is attractive to physicians since it is a safe, reliable and effective method 
for visualizing the entire small bowel. However, the disadvantages of CE are that it is a 
purely diagnostic test without therapeutic capabilities, there is no means to facilitate 
tissue biopsy, and accurate localization of findings can be difficult.43 Furthermore, it does 
not provide a real-time examination and cannot be steered back toward a suspected 
area of pathology to allow for further inspection. The main indications for CE are obscure 
GI bleeding, unexplained iron-deficiency anemia, known or suspected non-stricturing 
small bowel Crohn’s disease, refractory Celiac disease, hereditary polyposis syndromes, 
and suspected small bowel tumors.44
Overtube-assisted enteroscopy is both a diagnostic and therapeutic procedure with the 
potential for navigation of the entire small intestine by combining sequential oral and 
anal approaches.45 The major advantage over CE is the ability to obtain tissue biopsies, 
1
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as well as to perform therapeutic interventions such as hemostasis for bleeding, polyp-
ectomy, balloon dilation or placing ink tattoo at the site of pathologic findings to direct 
subsequent surgery.46 However, it is an invasive and lengthy procedure that requires 
deep sedation, typically with propofol, and has an increased risk for potentially serious 
complications, including intestinal perforation, bleeding and acute pancreatitis.47-49 
DBE was the first type of overtube-assisted enteroscopy and is the technique that has 
been adopted most widely. It consists of a 200 cm endoscope and a 140 cm flexible, 
polyurethane overtube, both of which are fitted at the distal tip with an inflatable latex 
balloon. The overtube balloon is inflated to grip the intestinal wall and hold it in place, 
preventing stretching of the intestine and allowing advancement of the endoscope 
without the formation of redundant loops of bowel. After advancement of the overtube 
to the distal tip of the endoscope, both balloons are simultaneously inflated while the 
endoscope and overtube are pulled back together in a shortening maneuver pleating 
the intestine back over the scope. This cycle is successively repeated as the endoscope 
is advanced through the small intestine. Single balloon endoscopy (SBE) is another form 
of overtube-assisted balloon enteroscopy that was introduced more recently in 2008.50 
SBE works in a similar manner as DBE, but there is a balloon only on the overtube and 
not on the endoscope, meaning that endoscope tip deflection combined with suction is 
used to “hook” the bowel wall to enable shortening, whereas this is accomplished more 
reliably by inflating the endoscope balloon with DBE. An even newer and entirely differ-
ent overtube-assisted technique is spiral enteroscopy, which utilizes a unique overtube 
that has raised helices at its distal end, a locking device to fix the overtube to the 
enteroscope, and two foam handles at its proximal end that are twisted to cause the 
overtube to rotate.51,52 Clockwise rotation of the spiral overtube acts in a manner similar 
to that of a screw, advancing the endoscope while pleating the bowel onto its surface. 
The spiral overtube can be used with either a DBE or a SBE endoscope (without balloon 
overtube) and enables rapid advancement deep into the small bowel. DBE, SBE and 
spiral enteroscopy may be performed via an anterograde approach through the mouth 
or via a retrograde approach through the anus. The majority of the research literature 
and the bulk of clinical experience involves DBE, whereas SBE and spiral enteroscopy 
remain more emerging technologies.43
Given the highly invasive nature of overtube-assisted enteroscopy, perhaps it should not 
be surprising to find complication rates for DBE that far exceed those for colonoscopy, 
with an overall adverse event rate of more than 1%.49 Indeed, the three most common, 
serious complications include bleeding (0.6%), intestinal perforation (0.3%) and acute 
pancreatitis (0.3%).47,48 The development of acute pancreatitis post-DBE was a surprising 
finding and its cause remains unclear. Multiple theories have been proposed and the 
technique for the initial advancement of the enteroscope has been accordingly modi-
14 Chapter 1
fied,53 yet hyperamylasemia and acute pancreatitis remains a concern for both DBE54 
and SBE.55
AIM OF THESIS
As outlined above, substantial innovation and significant improvements have been 
made in the field of GI endoscopy, but many challenges remain. Ongoing, continuous 
efforts are needed to help achieve the best possible practice of endoscopy, in terms 
of optimizing technical performance, clinical outcomes and patient safety. New ways 
of doing things and new solutions to longstanding challenges need to be considered, 
while new technologies must be critically evaluated to ensure that they are better and 
not simply newer. In this paper, these questions are asked first with respect to colonos-
copy and secondly with respect to small bowel endoscopy.
Despite more than four-decades experience with colonoscopy, clinically relevant 
limitations persist, not least being difficulties with incomplete procedures that result 
in suboptimal examinations, and challenges regarding procedural discomfort and 
safety that may affect patient willingness to undergo these tests. Therefore, techniques 
or strategies that improve the completion rate and/or comfort of colonoscopy are 
needed. In Chapter 2, a prospective, randomized controlled trial is presented that 
compared magnetic imaging-assisted colonoscopy to conventional colonoscopy with 
respect to patient comfort as well as procedural metrics such as cecal intubation rate 
and time-to-cecum. It was hypothesized that magnetic imaging would improve the 
performance of colonoscopy by enabling visualization of endoscope position and loop 
formation.
Recognizing that a proportion of colonoscopy procedures will invariably be incomplete, 
attention was next directed toward potential solutions to address this problem. A num-
ber of different strategies have been used in the past to overcome colonoscopy cases 
that are previously incomplete.56-59 Recently, techniques from small bowel endoscopy 
have been borrowed with the demonstration that DBE may successfully enable comple-
tion of previously failed cases.60-62 However, it was unclear if SBE, a newer method of 
overtube-assisted enteroscopy, was also a feasible and effective strategy for overcoming 
incomplete colon examinations. This study is presented in Chapter 3.
In Chapter 4, the new small bowel endoscopy techniques are further explored, focusing 
on the best strategy for evaluating patients with obscure GI bleeding (OGIB), the most 
common indication for small bowel investigations. OGIB is defined by the American 
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Gastroenterological Association as bleeding that persists or recurs without identifica-
tion of its source after negative esophagogastroduodenoscopy and colonoscopy.63 It is 
classified as “overt” when patients present with clinically evident manifestations such as 
hematemesis, hematochezia or melena, and “occult” when patients have iron-deficiency 
anemia or positive fecal occult blood testing. Approximately 5% of GI bleeds are thought 
to remain “obscure” after initial conventional work-up, with a presumed source of bleed-
ing attributed to the small intestine.63 Consequently, OGIB is the predominant reason 
why small bowel endoscopy is performed. However, it has remained unclear whether 
CE or DBE is the preferred first-line small bowel investigation for GI bleeding patients. 
Arguments can be made for why each test can justifiably be performed first,43 but the 
general consensus, although not uniformly shared, has been to begin with CE,64 par-
ticularly because CE is less invasive, has a reasonably good negative predictive value for 
rebleeding, and helps guide the route of insertion (oral vs. anal) of subsequent DBE if a 
culprit lesion is found.65-68 However, because CE is a purely diagnostic test, DBE is often 
still required to treat a bleeding source, which has provided the rationale for beginning 
with DBE in the first place.69 Added to this confusion is the persistent uncertainty as to 
whether a higher diagnostic yield is obtained by performing CE or DBE. In fact, there are 
no prospective, randomized controlled trials comparing CE and DBE that can answer 
this question. Two meta-analyses were previously performed that compared the diag-
nostic yields of CE and DBE, but these included all small bowel indications and were not 
restricted to bleeding patients.70,71 In order to address this question, a new meta-analysis 
was conducted that compared CE and DBE specifically in OGIB (Chapter 4).
When performing DBE, there are many factors that should be considered that may affect 
success in terms of insertion depth into the small bowel, clinical efficacy and patient 
comfort. Some of these variables include the prior use of purgative bowel prep, type of 
sedation, and use of CO2 rather than air for insufflation of the bowel.72-74 Creating the 
optimal conditions for success is important, particularly because DBE is highly invasive 
for patients, and very time consuming and labor intensive for endoscopists. In order to 
visualize most of the small intestine, DBE usually needs to be performed in two direc-
tions, in an anterograde fashion via the mouth and separately in a retrograde fashion via 
the anus. Typically, at least in Europe and North America, most endoscopists begin with 
the anterograde approach, progressing to the more technically challenging retrograde 
procedure75 only if the first approach does not yield the diagnosis or provide oppor-
tunity for necessary therapeutic interventions. However, there is uncertainty whether 
distal DBE should be performed immediately following an anterograde approach as a 
single bi-directional procedure, or whether doing so compromises the success of the 
retrograde DBE. To address this question, the technical success of retrograde DBE was 
examined between bi-directional cases, in which retrograde DBE immediately followed 
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an anterograde DBE, and uni-directional cases, in which retrograde DBE was performed 
on its own (Chapter 5).
One of the unexpected complications of DBE, as discussed previously, was the develop-
ment of acute pancreatitis in some patients post-procedure.76 Much more common than 
acute pancreatitis was the incidence of significant elevations of serum amylase, which 
were most often interpreted as evidence of subclinical pancreatic injury.77,78 In fact, mul-
tiple studies have characterized this phenomenon with DBE, despite modification of the 
enteroscopy technique to delay balloon inflation until distal to the major papilla.53,79,80 
Similar findings with respect to post-procedure hyperamylasemia have been observed 
with SBE, but without associated acute pancreatitis.81,82 However, it is unclear whether 
spiral enteroscopy, which involves rotation of a spiral overtube rather than inflation 
of balloons, may also be complicated by acute pancreatitis or hyperamylasemia. This 
question was addressed by the final study included in this paper that is presented in 
Chapter 6.
1
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ABSTRACT
Background and Aim: Optimizing performance of colonoscopy and improving its 
tolerability for patients is important. Magnetic imaging technology may improve 
performance by enabling visualization of loop formation and endoscope position. The 
purpose of this study was to compare magnetic imaging-assisted colonoscopy (MIC) 
with conventional colonoscopy (CC).
Methods: A prospective randomized trial was performed involving patients undergoing 
elective outpatient colonoscopy with randomization to MIC or CC. The primary outcome 
was patient comfort expressed by a visual analogue pain scale and by a sedation score. 
Secondary outcomes included endoscopic procedural metrics.
Results: Two hundred fifty-three patients were randomized and underwent MIC or CC. 
There were no differences in cecal intubation rates (100 vs. 99%), insertion distance-to-
cecum (82 vs. 83 cm), time-to-cecum (6.5 vs. 7.2 minutes), or polyp detection rate (47 vs. 
52%) between the MIC and CC groups. The primary outcomes of mean pain score (1.0 
vs. 0.9 out of 10; p=0.41) and sedation score (8.2 vs. 8.5; p=0.34) also did not differ be-
tween MIC and CC. Within a subgroup of cases considered more challenging or difficult, 
time-to-cecum was significantly faster with MIC compared to CC, 10.1 vs. 13.4 minutes 
respectively (p=0.01). Sensitivity analyses confirmed a similar pattern of overall findings 
when each endoscopist was considered separately.
Conclusions: The latest version of MIC was no better than CC in terms of endoscopic 
procedural metrics and patient experience outcomes, when performed in experienced 
hands. However, within a subgroup of more challenging cases, MIC produced faster 
times-to-cecum.
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INTRODUCTION
Colonoscopy decreases the likelihood of developing colorectal cancer (CRC) and CRC-
related mortality1-5 and is the CRC screening modality of choice.6 However, incomplete 
colonoscopy that fails to reach the cecum remains an important limitation, occurring 
in 10-20% of cases.7,8 Furthermore, a considerable proportion of the population remain 
averse to undergoing colonoscopy, particularly because of fears of procedure discom-
fort,9,10 decreasing the potential impact for overall CRC reduction. Thus, optimizing 
performance of colonoscopy and improving its tolerability for patients is important.
Colonoscopy is most successful at reaching the cecum and most comfortable for patients 
when the endoscope is kept in a straight position, achieved by minimizing loop forma-
tion and reducing loops once they have formed.11,12 To help overcome these challenges, 
real-time magnetic imaging-assisted colonoscopy (MIC) was developed that consisted 
of electromagnetic generator coils contained within a catheter inserted into the instru-
ment channel of the colonoscope.13 The coils produce a magnetic field detected by a 
series of sensors external to the patient, which triangulate the coil position in three-
dimensional (3D) space, giving rise to a computer-generated image of the shape of the 
endoscope on a monitor. The initial studies using this catheter-based magnetic imaging 
system demonstrated significant improvements in cecal intubation rates, time-to-
cecum, duration of time spent managing loops, and success of straightening attempts 
when colonoscopy was performed by trainees but not by experienced endoscopists.14 
Consequently, magnetic imaging technology has been generally regarded as a learning 
tool with limited clinical uptake outside of a training setting.
Recently, an updated version of MIC (ScopeGuide,™ Olympus America, Center Valley, PA) 
was developed that includes built-in electromagnetic coils embedded within the en-
doscope rather than in an inserted catheter, a thin and compact receiver dish mounted 
on a roll stand for convenient positioning during the procedure, integration of the 3D 
representation of the scope on the same screen as the endoscopic image, and an exter-
nal hand-held coil used to identify the optimal location for abdominal pressure relative 
to the endoscope. It is hoped that these features will make the second-generation of 
ScopeGuide more user friendly, while facilitating a more comfortable patient experience 
and technically successful procedure when being performed by endoscopists in clinical 
practice.
The purpose of this prospective, randomized trial was to determine if real time visu-
alization of the colonoscope using the new, second-generation ScopeGuide system is 
superior to conventional colonoscopy for improving patient experience in terms of re-
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duced discomfort and decreased sedation requirements, and for improving endoscopic 
procedural outcomes.
METHODS
Study design
Consecutive, adult patients (18 years or older) referred for elective, outpatient colo-
noscopy at the University of Alberta Hospital (Edmonton, Canada) were considered 
for enrollment. Patients were excluded if they were admitted to hospital or if they had 
active, ongoing lower GI bleeding, if they were undergoing colonoscopy without prior 
purgative bowel preparation or if they required anesthetist-administered propofol, if 
they had a history of previous colonic surgery, cardiac pacemaker or implantable cardio-
verter-defibrillator, or if the colonoscopy was to be performed by a trainee under staff 
supervision. Eligible patients who provided informed consent were then randomized 
to undergo conventional colonoscopy (CC) or MIC using the second-generation Scope-
Guide system, with patients, but not endoscopists, blinded to the randomization status. 
Simple, non-restricted randomization was performed using a computerized random-
number generator immediately prior to the procedure. The study protocol was approved 
by the Health Research Ethics Board of the University of Alberta (effective 08/09/2011) 
and registered with Clinicaltrials.gov (registered 09/18/2011; NCT01438645).
Colonoscopy procedure
Colonoscopy was performed by one of three experienced endoscopists as clinically in-
dicated. The control group underwent conventional colonoscopy using CF-H180AL vari-
able-stiffness colonoscopes (Olympus America). The investigational group underwent 
magnetic imaging-assisted colonoscopy using Olympus CF-H180DL variable-stiffness 
colonoscopes, which differ only by the incorporation of the ScopeGuide system that 
generates a 3D image on the monitor depicting the shape of the colonoscope inside 
the patient’s body (see Figure 1). Beyond the inclusion of ScopeGuide, the colonoscopy 
procedure did not differ between groups.
All patients received a purgative bowel preparation consisting of 4 L of a polyethylene 
glycol solution followed by an overnight fast (for morning procedures) or a 2 L/2 L split 
preparation (for afternoon procedures) according to the standard clinical practice at our 
center. Prior to the procedure, patients completed a visual analogue scale (VAS) reflect-
ing their predictions for expected discomfort. All procedures were then performed 
using conscious sedation consisting of a benzodiazepine and an opioid analgesic. 
Initially, all patients received standardized doses of midazolam 2 mg IV and fentanyl 25 
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mcg IV. Additional doses were then provided when the nurse or physician believed that 
the patient was becoming uncomfortable. Insufflation of the colon was accomplished 
using room air, and alternative methods such as CO2 were not permitted. In all cases, 
the endoscopist attempted to minimize the formation of loops within the colon and 
reduced any loops whenever possible according to standard clinical practice, using 
the additional guidance from the ScopeGuide image in the investigational group. The 
use of technical maneuvers to facilitate completion of the procedure were permitted, 
including external abdominal pressure, repositioning of the patient, or tightening of 
the variable-stiffness setting on the colonoscope. Any abnormalities or polyps detected 
during insertion were more closely inspected, biopsied or removed during subsequent 
colonoscope withdrawal. Any additional diagnostic or therapeutic applications were 
permitted as clinically indicated. During the case, the nurse documented all procedural 
data using a standardized reporting form. At the conclusion of the colonoscopy, the en-
doscopist rated the procedural difficulty as “usual” or “difficult” based on the procedure 
characteristics described above. Patients completed another VAS reflecting their actual 
degree of discomfort experienced once they were completely awake after spending 
more than one hour in the recovery area.
Outcome measurements
The primary outcome measure was the patient experience during colonoscopy, defined 
by patient comfort as expressed on a visual analogue pain scale and sedation require-
ments. Since the conscious sedation consisted of two different drugs, the doses of these 
drugs were converted into a single numerical score. By convention, typical dose incre-
ments of midazolam consist of 1 mg units whereas those of fentanyl consist of 25 mcg 
a b
Figure 1. ScopeGuide image of endoscope forming a reversed alpha loop in the sigmoid (a) and straight 
in the cecum (b).
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units, and each was assigned a numerical score of ‘1.’ These were then added together to 
generate a unified sedation score for each patient. Patient comfort was then determined 
from the post-procedure VAS, which consisted of a 10 cm linear scale ranging from ‘0’ at 
its extreme left representing “no pain” to ‘10’ on its extreme right representing “unbear-
ably severe pain.” The pain score was rated between 0.1 and 10.0, with a lower value 
representing a more comfortable procedure. Secondary outcome measures consisted 
of endoscopic procedural outcomes such as time-to-cecum, cecal intubation rate, polyp 
detection rate, and insertion distance of the colonoscope to the cecal pole. As part of a 
secondary analysis to account for patient expectations regarding procedural discomfort 
that might modify their actual perception of pain during colonoscopy, the VAS was also 
measured pre-procedure, and the pain difference was determined by subtracting the 
pre-procedure from the post-procedure pain score. Finally, sensitivity analyses were 
performed to determine if the findings were consistent across all three endoscopists, 
and within the subgroup of self-rated “difficult” procedures.
Statistical analysis
The statistical software Stata 10.1 (Stata Corp, College Station, TX) was used to analyze 
the data. Means and ranges were used to summarize data for continuous variables and 
percentages were used for categorical variables. Student’s t-test was used to compare 
the primary outcome of the composite score between the two groups, as well as for 
other continuous data. The Chi2 test was used to compare proportions for categorical 
data. A two-sided p ≤ 0.05 with 80% power was considered statistically significant (after 
correction for multiple comparisons). Multivariate regression was used to perform the 
sensitivity analyses. A sample size calculation was performed to detect a difference of 
0.5 (out of the 10 point VAS scale) in the mean pain scores between the CC and MIC 
groups. Based on a predicted pain score of 1.5 in the CC group and 1.0 in the MIC group, 
it was estimated that 126 patients (63 in each group) would be required to demonstrate 
a statistically significant difference.
RESULTS
Between September 2011 and October 2012, 253 patients participated in the study; 
mean age 58 years (range: 18–86); 52% male. The indications for colonoscopy and other 
patient characteristics are shown in Table 1. One hundred twenty-two patients (48%) 
underwent CC and 131 (52%) had MIC. Complete colonoscopy was accomplished in 121 
cases (99%) in the CC group and 131 cases (100%) in the MIC group. Incomplete colo-
noscopy occurred in one case due to a failed bowel preparation that left formed stool 
obstructing the mid-transverse colon. The mean endoscope insertion distance was 83 
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Table 1. Patient characteristics
Conventional 
colonoscopy
(n = 122)
Magnetic imaging 
colonoscopy
(n = 131)
Total
(n = 253)
Age 58.2 (18 – 82) 57.7 (19 – 86) 57.9 (18 – 86)
Gender – male (%) 63 (51.6%) 68 (51.9%) 131 (51.8%)
Previous colonoscopy 77 (63.1%) 66 (50.4%) 143 (56.5%)
Prior abdo or pelvic surgery 19 (15.6%) 26 (19.9%) 45 (17.8%)
Indication
a) Screening or polyp follow-up 71 (58.2%) 79 (60.3%) 150 (59.3%) 
b) GI bleeding 13 (10.7%) 23 (17.6%) 36 (14.2%) 
c) Anemia or FOBT+ 7 (5.7%) 10 (7.6%) 17 (6.7%) 
d) Diarrhea 5 (4.1%) 11 (8.4%) 16 (6.3%) 
e) IBD 8 (6.6%) 4 (3.1%) 12 (4.7%) 
f ) Other 18 (14.8%) 4 (3.1%) 22 (8.7%) 
Table 2. Endoscopic outcomes
Conventional 
colonoscopy
(n = 122)
Magnetic imaging 
colonoscopy
(n = 131)
Total
(n = 253)
p
Cecal intubation 121 (99.2%) 131 (100%) 252 (99.6%) 0.30
TI intubation 42 (34.4%) 46 (35.1%) 88 (34.8%) 0.91
Distance to cecum (cm) 83.0
(53 – 130)
82.4
(49 – 150)
82.7
(49 – 150)
0.71
Time-to-cecum (min) 7.2
(2 – 29.5)
6.5
(1.2 – 28)
6.9
(1.2 – 29.5)
0.18
Total procedure time (min) 16.7
(8.1 – 36)
15.7
(5.7 – 40)
16.2
(5.7 – 40)
0.19
Polyp detection rate 51.6%
(0.43, 0.61)
46.6%
(0.38, 0.55)
49.0% 0.42
Mean # polyps
(range)
1.7
(1 – 7)
1.9
(1 – 8)
1.8
(1 – 8)
0.36
Quality of bowel prep
a) excellent 21.3% 29.8% 25.7%  
b) acceptable 49.2% 43.5% 46.3%  
c) fair 25.4% 24.4% 24.9%  
d) poor 4.1% 2.3% 3.2%  
Procedures self-rated as “difficult” 25 (20.5%) 36 (27.5%) 61 (24.1%) 0.19
Sedation, mean doses (range)
Midazolam (mg) 5.8 (3 – 15) 5.5 (2 – 15) 5.7 (2 – 15) 0.31
Fentanyl (mcg) 86.3 (50 – 150) 83.2 (50 – 150) 84.7 (50 – 
150)
0.29
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cm (range, 53-130) in the CC group and 82 cm (range, 49-150) in the MIC group (p=0.71), 
with a mean time-to-cecum of 7.2 minutes (range, 2-30) and 6.5 minutes (range, 1-28) 
respectively (p=0.18). Polyps were detected in 52% of cases in the CC group and in 
47% of cases in the MIC group (p=0.42), with a mean of 1.7 (range, 1-7) and 1.9 (range, 
1-8) polyps, respectively. No adverse events were recorded. See Table 2 for endoscopic 
procedural metrics.
The outcomes regarding patient comfort and sedation are shown in Table 3. The primary 
endpoints of pain score (0.9 vs. 1.0; p=0.41) and sedation score (8.5 vs. 8.2; p=0.34) did not 
differ between the CC and MIC groups, nor did the secondary endpoint pain difference 
(-1.3 vs. -1.8; p=0.14). A similar pattern was observed in the subgroup of 61 procedures 
(24%) self-rated by the endoscopist as being “difficult” (see Table 4), in which there were 
no significant differences between the CC and MIC groups with respect to these patient 
comfort metrics, However, time-to-cecum was significantly shorter with MIC compared 
to CC among this subgroup of “difficult” cases, with mean times of 10.1 minutes (range, 
3.8-28) and 13.4 minutes (range, 6.7-29.5), respectively (p=0.01).
Table 3. Patient experience outcomes
Conventional 
colonoscopy
(n = 122)
Magnetic imaging 
colonoscopy
(n = 131)
Total
(n = 253)
p
Sedation score 8.5 (4.5 – 17) 8.2 (4 – 21) 8.3 (4 – 21) 0.34
Pretest Pain score 2.2 (0.1 – 8.5) 2.9 (0.1 – 9) 2.5 (0.1 – 9) 0.02
Post pain score 0.85 (0.1 – 8.4) 1.03 (0.1 – 10) 0.94 (0.1 – 10) 0.41
Pain difference - 1.3 - 1.8 - 1.6 0.14
Table 4. Subgroup of self-rated “difficult” colonoscopy procedures
Conventional 
colonoscopy
(n = 25)
Magnetic imaging 
colonoscopy
(n = 36)
Total
(n = 61)
p
Time-to-cecum (min) 13.4
(6.7 – 29.5)
10.1
(3.8 – 28)
11.5
(3.8 – 29.5)
0.01
Distance to cecum (cm) 91.2
(68 – 130)
85.7
(49 – 150)
88.0
(49 – 150)
0.30
Sedation score 9.54
(5 – 17)
9.08
(5 – 21)
9.27
(5 – 21)
0.61
Post pain score 1.48
(0.1 – 8.4)
1.15
(0.1 – 7.9)
1.28
(0.1 – 8.4)
0.53
Pain difference - 1.05
(-6.8 – 3.3)
- 1.50
(-7.8 – 4.9)
- 1.32
(-7.8 – 4.9)
0.54
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When sensitivity analyses were performed to determine if the same pattern of find-
ings were observed for each endoscopist when considered separately, no differences 
emerged between the CC and MIC groups with respect to endoscopic procedural met-
rics such as cecal intubation rate, time-to-cecum, insertion distance to cecum or polyp 
detection rate.
DISCUSSION
Optimizing the technical performance of colonoscopy and its tolerability for patients 
is important. The development of magnetic imaging technology that enables real time 
visualization of the shape of the entire endoscope within the patient’s body was antici-
pated to help achieve that aim. In this randomized trial, MIC using the latest generation 
of ScopeGuide was compared to CC with regards to patient comfort based on a post-
procedure VAS pain score and a sedation score derived from standard dose increments 
of conscious sedation medications. However, MIC did not prove to be superior to CC for 
this primary outcome, nor for any of the secondary outcomes such as cecal intubation 
rate, time-to-cecum, endoscope insertion distance-to-cecum, or polyp detection rate. 
Thus, it appears that in general, MIC does not improve the technical performance of 
colonoscopy or the overall patient experience. Only within the subgroup of cases self-
rated by the endoscopist as “difficult” did any differences emerge, with MIC achieving 
significantly faster times-to-cecum compared to CC, but with no differences in patient 
experience outcomes.
This study has several limitations that may affect the generalizability of the results. Firstly, 
the primary outcome of pain score and sedation score contain inherent biases, chiefly 
that increased sedation could be used to overcome greater procedural discomfort, po-
tentially creating an apparent, but false, difference in pain score modified by the amount 
of sedation used. The most effective means to compare patient tolerability between MIC 
and CC would have been to perform unsedated colonoscopy, using the VAS to compare 
patient comfort between the techniques. Such strategies have been used in previous 
studies that evaluated the use of variable-stiffness colonoscopes.15,16 However, our local 
patient population is generally resistant to the concept of unsedated procedures and 
this was deemed to not be viable. In any event, neither the visual analogue pain score 
nor the sedation score differed between groups, indicating that this potential for bias did 
not lead to confounding of the overall results. A second limitation was the performance 
of all procedures by individuals who have undergone advanced fellowship training in 
therapeutic endoscopy, for whom magnetic imaging assistance for routine colonoscopy 
was perhaps less likely to be of value. In hindsight, it would have been more informative 
32 Chapter 2
to include all endoscopists performing colonoscopy at our center, which would have 
provided a more diverse range of levels of experience and expertise that may have led to 
the identification of individuals for whom MIC was truly beneficial. Finally, the classifica-
tion of procedural difficulty based on the subjective self-rating of the endoscopist was 
prone to bias, and the lack of objective criteria for classifying cases as challenging limits 
the generalizability of the finding that faster times-to-cecum were achieved with MIC 
within the subgroup of these difficult cases. However, since the classification of cases 
as “difficult” was done quite liberally (one-fourth were considered as such), there were 
likely sufficient numbers in this subgroup to provide a meaningful comparison, even 
though the study was not powered for subgroup analysis. Nevertheless, the demonstra-
tion of a significant difference in time-to-cecum for difficult cases between MIC and CC 
is at least hypothesis generating.
The main benefit derived from magnetic imaging assistance is the accurate identifi-
cation and proper straightening of endoscope loops,17 as well as visualization of the 
endoscope position within the different regions of the colon, which conceivably should 
facilitate faster and more comfortable procedures, while enabling the accurate localiza-
tion of polyps or other pathology. While our study suggests MIC is unnecessary in most 
cases when colonoscopy is performed in experienced hands, there is good reason to 
speculate that magnetic endoscope imaging may benefit less experienced endoscopists 
and trainees. The cecal intubation rate in this trial was 99.6%, whereas large database 
studies of real life clinical outcomes reveal rates of incomplete colonoscopy ranging 
from 13-35%,7,8,18 demonstrating the likely need for additional tools to facilitate the 
performance of colonoscopy in non-expert settings. Whether MIC can help improve 
these rates of complete colonoscopy, and whether it would be cost effective to do so 
given the added expense of ScopeGuide, remains unclear and requires further study. 
Regarding the likely benefit of magnetic imaging assistance during training, the initial 
study that evaluated the previous version of MIC demonstrated significant improve-
ments in procedural metrics in cases performed by trainees.14 More recently, a one-day 
training program at Stanford that used the older version of ScopeGuide as part of a 
simulator consisting of a soft plastic colon model mounted within a real-shaped body 
torso, led to significant improvements in subsequent colonoscopy performed on live 
patients without magnetic imaging assistance.19 The trainees demonstrated improve-
ments in their overall performance, as well as in cecal intubation rates, time-to-cecum 
and sedation requirements following the ScopeGuide training intervention. Thus, there 
is reason to speculate that magnetic endoscope imaging could become an essential 
training tool, forming the basis of a graduated process that transitions learners from 
computer simulation to unassisted colonoscopy. However, further study will be needed 
to verify this recommendation.
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In summary, the latest version of magnetic imaging-assisted colonoscopy (ScopeGuide) 
performed no better than conventional colonoscopy in terms of endoscopic procedural 
metrics and patient experience outcomes, when performed in experienced hands. How-
ever, within a subgroup of more challenging cases, MIC may result in faster times-to-
cecum. Nevertheless, the greatest utility of MIC may exist as a graduated training tool or 
to assist non-expert endoscopists, although this requires further study.
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ABSTRACT
Background: Despite advances in training and equipment, complete colonoscopy fails 
even in experienced hands in up to 10% of cases. Double balloon endoscopy (DBE) 
has been successfully used to complete colonoscopy in these patients. Single balloon 
endoscopy (SBE) has become established for small bowel enteroscopy. However, it has 
yet to be studied for use in colonoscopy.
Objective: To assess the efficacy, performance and safety of single-balloon colonoscopy.
Design: Prospective cohort study.
Setting: Academic tertiary referral center.
Patients: Patients with previously failed conventional colonoscopy.
Results: 23 single-balloon colonoscopy procedures were performed in 22 patients: 
median age 53 (range 19-75) years; 14 females, 8 males. SBE colonoscopy succeeded 
in cecal intubation in 22 (96%) procedures, with a median total procedure time of 30 
(range 20-60) minutes. SBE colonoscopy was normal in 9 cases but resulted in a positive 
diagnosis in 13 (57%) procedures, including polyps (n=6), active Crohn’s disease (n=4), 
Crohn’s-related stricture (n=1), and diverticulosis (n=2). Seven (30%) procedures were 
therapeutic including 1 case with balloon dilation and 6 cases with polypectomy. No 
complications were encountered.
Limitations: Limited sample size, no direct comparison with double-balloon endoscopy.
Conclusions: Single-balloon assisted colonoscopy seems a safe and effective method 
for completing colonoscopy in patients with previously failed or difficult colonoscopy. 
The outcomes are similar compared to previous studies with DBE colonoscopy in this 
patient group.
Single-balloon assisted colonoscopy in patients with previously failed colonoscopy 39
3
INTRODUCTION
Colonoscopy is the gold standard examination of the colon, and complete inspection 
to the cecum is important for all patients who undergo the procedure, particularly for 
the detection and removal of adenomatous polyps and colorectal cancer.1 The U.S. 
Multi-Society Task Force on Colorectal Cancer has established target cecal intubation 
rates of 90% for all colonoscopies and greater than 95% for colonoscopies performed 
for colorectal cancer screening.2 However, a population-based study from Canada that 
examined the records from over 330,000 colonoscopy procedures found that 13% of 
these studies failed to reach the cecum.3 Furthermore, a recent large single-center series 
from the Netherlands demonstrated an 83% completion rate.4 Multiple patient factors 
have been identified that increase the difficulty of colonoscopy and make successful 
cecal intubation more unlikely, including older patient age, female gender, diverticular 
disease, a low body mass index, prior abdominal or pelvic surgery, insufficient colon 
cleansing, long redundant colon loops, and a fixed, angulated sigmoid colon.3-9 In re-
cent years, the relatively new technique of double-balloon endoscopy (DBE) has been 
successfully applied to enable complete colon inspection in patients with previously 
incomplete colonoscopies.10 Since the advent of DBE, single-balloon endoscopy (SBE) 
has become established as an alternative method of small bowel endoscopy, for both 
anterograde procedures via the mouth and retrograde procedures via the colon.11-13 
However, SBE has yet to be studied specifically for the completion of previously failed 
conventional colonoscopy. We report here our early experience using SBE to perform 
colonoscopy in patients in whom previous conventional colonoscopy was unsuccessful.
METHODS
Patients in whom a previous attempt with conventional colonoscopy failed to reach 
the cecum were prospectively enrolled for inclusion in the present study. The study was 
performed in a single, tertiary referral university hospital. Patients who had undergone 
a failed colonoscopy at our own institution proceeded directly to single-balloon assisted 
colonoscopy. Patients referred from other hospitals first underwent repeat colonoscopy 
at our center prior to being enrolled for single-balloon colonoscopy, unless a second, 
repeat colonoscopy had already been attempted at the referring center. Patients pro-
vided informed consent prior to undergoing single-balloon colonoscopy. The study was 
approved by the institutional review board of Erasmus MC University Medical Center.
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Single-balloon assisted colonoscopy procedure
All patients underwent the standard colonoscopy bowel preparation used at our institu-
tion, which consists of 4 L of a polyethylene glycol solution and an overnight fast from 
midnight. Single-balloon colonoscopy was performed using the Olympus SIF-Q160Y 
endoscope (Olympus Optical Co., Tokyo, Japan), ST-SB-1 overtube with balloon, and bal-
loon control unit. The technical specifications of the Olympus single-balloon endoscope 
and overtube have previously been described in detail, as has the technique of perform-
ing SBE.11, 12, 14, 15 The single-balloon colonoscopy technique employed was identical to 
the colonic portion of retrograde SBE. In detail, the endoscope was inserted via the anus 
in a similar fashion as when performing conventional colonoscopy, with the overtube 
pulled back to the proximal end of the shaft of the endoscope. Once sufficient length of 
the endoscope had been inserted such that the distal end of the overtube was brought 
forward to the anus, the overtube was then slid over the endoscope with its balloon 
deflated. Once the overtube had been advanced, its balloon was inflated to anchor the 
bowel wall, and the endoscope was inserted further. At the point of maximal insertion, 
the balloon was deflated and the overtube was re-advanced over the endoscope. Once 
fully inserted, the balloon on the overtube was inflated while the scope tip was angled 
toward the bowel wall to “hook” the bowel, and both scope and overtube were pulled 
back together in order to pleat the bowel over the overtube and reduce any colonic 
loops. This cycle of advancing the endoscope, deflating the balloon, advancing the over-
tube, inflating the balloon, hooking the bowel and then pulling both the overtube and 
endoscope back together was repeated until the endoscope had successfully entered 
and inspected the cecum. The withdrawal process was simply the reverse of the inser-
tion cycle. All procedures were performed by a single endoscopist (P.M.) with extensive 
experience with both DBE and SBE, together with an endoscopy nurse assistant.
Conscious sedation was used in the majority of procedures, using a combination of 
midazolam and fentanyl intravenously. In selected cases propofol sedation was admin-
istered.
The primary endpoint of the study was the rate of complete colonoscopy, defined as 
successful cecal intubation with photo-documentation of recognized cecal landmarks. 
Secondary outcomes included endoscopic procedural data such as diagnostic yield, 
therapeutic benefit, procedure time, rate and extent of terminal ileum intubation, com-
plications, and patient demographic data.
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RESULTS
Twenty-three single-balloon colonoscopy procedures were performed in 22 patients 
between January 2008 and November 2009. All patients were referred for single-balloon 
colonoscopy because of previously failed conventional colonoscopy: 14 (64%) females; 
median age 53 (19 – 75) years; 7 (32%) patients were referred from other hospitals for 
balloon-assisted colonoscopy at our center; 3 of these patients first underwent a repeat 
colonoscopy attempt at our center that was unsuccessful before proceeding to single-
balloon colonoscopy, while the remaining 4 patients had already undergone a failed 
second colonoscopy at the referring center. The main indications for colonoscopy were 
the evaluation of Crohn’s disease activity or investigation of suspected inflammatory 
bowel disease (43%), polyp(s) seen on radiology studies or on prior colonoscopy that 
could not be reached by the endoscope for removal (17%), and iron-deficiency anemia 
(13%); see Table 1.
Table 1: Individual data of patients, findings and therapy.
Patient Sex Age Indication Cecum 
intubation
Total 
procedure
time (min)
Diagnosis Intervention
1 F 26 Suspected IBD Yes 35 Normal
2 F 74 Polyp seen on 
previous colonoscopy; 
unable to reach the 
polyp
Yes 32 Polyp in R colon (10 
mm)
Polypectomy
3 M 70 Anemia Yes 35 Normal
4 F 75 Polyp on barium 
enema
Yes 60 Polyp in cecum (15 
mm)
Polypectomy
5 M 61 Anemia Yes 30 Diverticulosis
6 M 74 Polyp on barium 
enema
Yes 35 Multiple polyps (5 – 
15 mm)
Polypectomy
7 M 52 Anemia Yes 30 Normal
8 F 38 Evaluation of CD 
activity
Yes 36 Mildly active CD 
in TI
Step-up medical 
therapy
9 F 62 CRC family history Yes 30 Polyp in left colon 
(10 mm)
Polypectomy
10 F 51 Abdominal pain Yes 30 Normal
11 M 36 Suspected IBD Yes 20 Polyp in rectum (15 
mm)
Polypectomy
12 F 74 Abdominal pain Yes 30 Diverticulosis
13 F 62 Rising CEA post-
treatment for colon 
CA
Yes 20 Normal
14 F 48 Suspected IBD Yes 20 Normal
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Single-balloon colonoscopy resulted in successful cecal intubation in 22 (96%) proce-
dures, with a median total procedure time of 30 (range 20-60) minutes. No external 
abdominal compression or fluoroscopic guidance was employed during the procedures. 
One procedure failed at the hepatic flexure due to the accumulation of solid colonic 
debris within the overtube because of a poorly prepped colon, leading to impaired 
smooth movement of the endoscope within the overtube, which made advancement 
difficult. In 12 (53%) procedures the terminal ileum was intubated and was inspected 
for a median length of 28 (range 5-80) cm. However, this was only attempted in patients 
for whom it was thought to be clinically relevant. The single-balloon colonoscopy pro-
vided a diagnosis in 13 (57%) cases, including polyps (n=6), active Crohn’s disease (n=4), 
Crohn’s-related stricture (n=1), and diverticulosis (n=2). Therapeutic interventions were 
performed in 7 (30%) procedures: polypectomy in 6 and 1 balloon dilation. Polypectomy 
yielded 2 tubulovillous adenomas with high-grade dysplasia, 2 tubulovillous adenomas 
with low-grade dysplasia, 1 tubular adenoma, and 1 juvenile polyp. Four small (< 5 mm) 
polyps were removed, but not retrieved for histology.
Table 1: Individual data of patients, findings and therapy. (continued)
Patient Sex Age Indication Cecum 
intubation
Total 
procedure
time (min)
Diagnosis Intervention
15 F 47 Evaluation of CD 
activity
Yes 20 Mod-severely 
active CD in neo-
terminal ileum
Surgical 
resection
16 F 52 CRC family history Yes 30 Normal
17 F 44 Obstructive 
complaints
Yes 20 Normal
18 F 39 Evaluation of CD 
activity
No 60 Failed procedure
19 F 40 Evaluation of CD 
activity
Yes 20 Mildly active CD in 
colon
Step-up medical 
treatment
20 M 44 Evaluation of CD 
activity
Yes 30 Normal
21 M 67 Polyp seen on 
previous colonoscopy; 
unable to reach the 
polyp
Yes 30 Polyp in cecum 
(sessile, 25 mm)
EMR
22-1 M 19 Evaluation of CD 
activity
Yes 30 Stricture in 
transverse colon; 
unable to pass 
scope
Balloon dilation 
to 18 mm. Able 
to pass stenosis 
after dilation, 
subsequently 
started on 
adalimumab
22-2 M 19 Evaluation of CD 
activity
Yes 30 Improved stenosis; 
minimal CD activity
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Twenty-one (91%) procedures were performed under conscious sedation. Propofol 
sedation was used in the remaining two (9%) procedures. Patients received conscious 
sedation consisting of midazolam and fentanyl, with median doses of 5.0 mg and 0.075 
mg respectively during single-balloon colonoscopy, compared to median doses of 5.0 
mg and 0.05 mg during the previous, failed colonoscopy. There was no statistical differ-
ence in the doses of midazolam (p=0.99) or fentanyl (p=0.34) given during conventional 
colonoscopy or single-balloon colonoscopy. However, sedation data from the previously 
failed colonoscopy were only available for 16 patients. There were no complications with 
any procedure.
DISCUSSION
This study demonstrates the viability of using the single-balloon endoscope system 
for colonoscopy in patients with previously failed conventional colonoscopy. In our 
cohort of patients among whom prior attempts at complete colonoscopy had failed, 
single-balloon colonoscopy proved to be an effective and safe method for completing 
colonic examination with a 96% success rate and no complications, yielding a positive 
diagnosis in over half of the procedures and endoscopic therapeutics in 30% of cases, 
with a median total procedure time of 30 minutes. The major limitation of this study 
is its lack of an active comparison with other endoscopic methods such as repeating 
conventional colonoscopy or other overtube-assisted modalities. Our results are similar 
to those achieved in studies using DBE to complete previously failed colonoscopy, in 
which successful cecal intubation was achieved in 88-100% of patients.16-21 In the largest 
such study,21 successful DBE colonoscopy was achieved in 93% of patients, with a mean 
time-to-cecum of 19 minutes. A further limitation of our study is that ‘time-to-cecum’ 
was not recorded and only ‘total procedure time’ was available for comparison. However, 
other studies of DBE colonoscopy have illustrated procedure times that are no faster 
than those in this study, with mean time-to-cecum of 28 minutes in one study16 and 
mean total procedure time of 51 minutes in another.20 Certainly there is no evidence to 
suggest that SBE colonoscopy is a slower method than DBE colonoscopy.
When the relative merits of SBE and DBE for small bowel enteroscopy are considered, 
there are some advantages of SBE that may also hold true for single-balloon colonos-
copy. In particular, SBE may be easier to learn and more intuitive to perform for the 
practicing gastroenterologist,11, 12, 14, 22 SBE may be faster to perform because of having 
only one balloon cycle as opposed to two with DBE, and the Olympus single-balloon 
endoscope is stiffer than the Fujinon double-balloon endoscope, which may be par-
ticularly helpful when maneuvering through redundant loops of bowel. We believe the 
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particular advantages of SBE may be especially useful when using the SBE endoscope 
to examine the colon, and that its potential disadvantage when compared to DBE, pos-
sible inferior insertion depth into the small intestine, is not an important factor when 
considering the use of SBE for colonoscopy.
In conclusion, single-balloon assisted colonoscopy seems a safe and effective method 
for completing colonoscopy in patients with previously failed or difficult colonoscopy. 
The outcomes are similar compared to previous studies with DBE colonoscopy in this 
patient group. As clinical experience with DBE and SBE has accumulated, it has become 
clear that both techniques offer an effective solution for completing difficult colonos-
copy in patients with previously failed attempts.
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ABSTRACT
Background and Aim: Uncertainty remains about the best test to evaluate patients with 
obscure gastrointestinal bleeding (OGIB). Previous meta-analyses demonstrated similar 
diagnostic yields with capsule endoscopy (CE) and double balloon enteroscopy (DBE) 
but relied primarily on data from abstracts and were not limited to bleeding patients. 
Many studies have since been published. Therefore, we performed a new meta-analysis 
comparing CE and DBE focused specifically on OGIB.
Methods: A comprehensive literature search was performed of comparative studies 
using both CE and DBE in patients with OGIB. Data were extracted and analyzed to 
determine the weighted pooled diagnostic yields of each method and the odds ratio for 
the successful localization of a bleeding source.
Results: Ten eligible studies were identified. The pooled diagnostic yield for CE was 62% 
(95% CI 47.3-76.1) and for DBE was 56% (95% CI 48.9-62.1), with an odds ratio for CE 
compared to DBE of 1.39 (95% CI 0.88-2.20; p=0.16). Subgroup analysis demonstrated 
the yield for DBE performed after a previously positive CE was 75.0% (95% CI 60.1-90.0), 
with the odds ratio for successful diagnosis with DBE after a positive CE compared to 
DBE in all patients of 1.79 (95% CI 1.09-2.96; p=0.02). In contrast, the yield for DBE after 
a previously negative CE was only 27.5% (95% CI 16.7-37.8).
Conclusions: CE and DBE provide similar diagnostic yields in patients with OGIB. How-
ever, the diagnostic yield of DBE is significantly higher when performed in patients with 
a positive CE.
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INTRODUCTION
Obscure gastrointestinal bleeding (OGIB) is the clinical condition in which patients 
with hemorrhage from the gastrointestinal tract have no source of bleeding identi-
fied after conventional upper endoscopy and ileocolonoscopy.1 In the past decade, 
capsule endoscopy (CE)2 and double balloon enteroscopy (DBE)3 have revolutionized 
the approach to OGIB. No randomized, controlled trials exist comparing CE and DBE 
in OGIB, giving rise to uncertainty as to the best initial test to perform. Currently, the 
prevailing opinion is that patients should be investigated first by CE,4 although two 
economic analyses5, 6 have found that initial DBE is a more cost-effective strategy. Two 
meta-analyses comparing CE and DBE have previously been published, both finding 
similar overall diagnostic yields between the two modalities.7, 8 However, these analyses 
relied on a small number of observational studies that were predominantly reported 
only in abstract form. In addition, the relative yields of CE and DBE were compared 
for the investigation of small bowel diseases, and were not specifically restricted to 
patients with OGIB. Furthermore, many new studies comparing CE and DBE have 
been published since these 2 systematic reviews were performed, greatly expanding 
the published literature on this topic. Thus, we chose to perform a new meta-analysis 
focused on the diagnostic yield of CE and DBE specifically in OGIB, in order to assess 
whether the accumulation of new data provide a more definitive answer for what is the 
best management strategy in these patients.
METHODS
Search strategy and selection of studies
A comprehensive literature search was performed to identify all published articles that 
presented original data from a comparative study examining the combined use of both 
balloon assisted enteroscopy (BAE), either DBE or single balloon enteroscopy (SBE), and 
CE in patients with OGIB. The search was performed using the PubMed, MEDLINE, EM-
BASE, and the Cochrane Library electronic databases through to January 1, 2010. Also, 
abstracts were searched from the conference proceedings of Digestive Diseases Week 
2007, 2008 and 2009. The criteria for inclusion were published studies of any design that 
compared BAE and CE in the same patients with OGIB (both overt and occult). Studies 
that examined a broader population of patients with other indications for small bowel 
investigations were only included if the specific results for the subgroup of patients with 
GI bleeding could be discerned or were provided upon request by the study’s authors. 
Non-comparative studies that utilized only CE or only BAE but not both procedures were 
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excluded. Abstracts older than 3 years not subsequently published as full articles were 
also excluded. The following MeSH headings and keywords were used in the search 
strategy: capsule endoscopy, wireless capsule endoscopy, video capsule endoscopy, 
double balloon endoscopy, double balloon enteroscopy, single balloon endoscopy, 
single balloon enteroscopy, push-and-pull endoscopy, push-and-pull enteroscopy, and 
balloon assisted endoscopy. The search was not limited to ‘obscure GI bleeding’ so that 
potentially relevant papers would not be excluded. The search was restricted to studies 
performed in humans and published in English. Finally, a manual hand-search of the 
reference lists from all retrieved original studies was performed.
The selection of studies took place in two phases. Initially, one reviewer (C.T.) screened 
the titles and abstracts of all unique references identified from the search for broad 
relevance, excluding those studies that clearly did not meet inclusion criteria, and se-
lecting the remainder for closer scrutiny. These studies were then retrieved as full texts 
and independently assessed by two reviewers (P.M. and C.T) for relevance based on the 
inclusion and exclusion criteria. Where disagreement arose with respect to inclusion of a 
study, resolution was reached through discussion between the two reviewers.
Assessment of study quality
The quality of the studies was assessed using the STARD (STandards for the Reporting 
of Diagnostic accuracy studies) statement,9-11 which is a validated checklist consisting 
of 25 items designed to improve the quality of reporting in diagnostic accuracy studies 
(see http://www.stard-statement.org) that has recently been applied to endoscopy.12 
The STARD checklist, modified by the removal of 4 items (#7, #13, #22, #24; giving a total 
possible score of 21) that we considered to not be applicable to studies comparing BAE 
and CE, was used to evaluate the quality of reporting in each of the included studies. 
The assessment of study quality were independently performed by two reviewers (P.M. 
and C.T.) after consensus was first agreed upon as to what was required to satisfy each 
of the STARD criteria. Studies with modified STARD scores of 17-21 were classified as 
“excellent quality,” 12-16 “good quality,” 7-11 “moderate quality,” and < 7 “poor quality.” 
Interobserver agreement was calculated and the strength of agreement (κ coefficient) 
classified according to standard definitions.13
Data extraction and analysis
Data were extracted on the diagnostic yield of DBE (as there were no SBE studies) and 
CE for identifying the source of bleeding, and were then entered into Review Manager 
(Cochrane Collaboration, Version 5.0) and pooled using weights derived from Mantel-
Haenszel inverse variance. Heterogeneity was tested using a chi-square method and a 
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p-value of less than 0.1 was considered to reflect significant heterogeneity. Risk of bias 
was assessed using funnel plot analysis. Meta-analysis was performed using a random 
effects model to determine the odds ratio with 95% confidence intervals for the success-
ful localization of the source of obscure GI bleeding comparing CE and DBE. In addition, 
pooled diagnostic yields for CE and for DBE were separately calculated using weightings 
based on Mantel-Haenszel inverse variance. Subgroup analyses of the diagnostic yields 
of DBE performed after a previously positive CE or a previously negative CE were con-
ducted. Tests of statistical significance were performed using the paired and unpaired 
t-test with Stata 10.1 (Stata Corp, College Station, Texas) and with the Cochrane Col-
laboration Review Manager.
RESULTS
Description of studies
A flow diagram illustrating the study selection process is shown in Figure 1. One hundred 
forty-seven unique references were initially identified by the search, of which ten studies 
met all inclusion criteria.14-23 In fact, fourteen studies met the criteria for inclusion in the 
systematic review, but 4 of these papers24-27 were ultimately excluded from the meta-
analysis because in these studies DBE was only performed in patients with a previously 
positive CE, which represents a selected patient population compared to patients with 
OGIB undergoing both CE and DBE.
A summary of the ten selected studies is provided in Table 1. No randomized-controlled 
trials were identified. DBE was used to perform balloon-assisted endoscopy in all 
included studies, with no study comparing SBE and CE. There were 651 patients who 
underwent CE and 642 patients who underwent DBE. This discrepancy in the number 
of patients who had CE and DBE exists because in the study by Fujimori et al.,15 nine pa-
tients underwent CE but not subsequent DBE, without separate results being reported. 
In nearly all cases CE preceded DBE, except for one study18 in which patients underwent 
DBE prior to CE, and a second study21 in which CE was not uniformally performed before 
or after DBE. With only two exceptions,14, 18 all studies examined a mixed population of 
OGIB patients, reporting combined results for both those with overt and occult manifes-
tations of GI bleeding.
The assessments of study quality using the STARD statement criteria are presented in 
Table 1. The mean score was 16.1 (range 10 – 20; out of a possible score of 21). Five 
studies were considered to be of excellent quality,14, 17, 19, 22, 23 four of good quality,15, 16, 18, 21 
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and one study as moderate quality.20 The overall interobserver agreement was 86.2% 
giving a kappa of 0.62, indicating substantial agreement.
Diagnostic yields of CE and DBE
The efficacy outcomes from the studies included in the meta-analysis are presented in 
Table 2. The pooled diagnostic yield for CE was 61.7% (95% CI 47.3-76.1) and for DBE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Unique references identified and 
screened for retrieval  
n = 147 
References retrieved for more 
detailed evaluation by 2 reviewers 
n = 50 
Titles & abstracts excluded  
after preliminary review (n = 97) 
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 Review/editorial; n = 22 
Potentially appropriate studies to be 
included in the meta-analysis 
n = 14  
Papers excluded after full review  
(n =36) 
 Wrong topic; n = 8 
 Not comparative; n = 10 
 Review/editorial; n = 13 
 Inappropriate patient 
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Papers included in meta-analysis 
n = 10 
Papers excluded from meta-analysis 
because DBE only performed in 
patients with positive CE 
n =4 
Figure 1. Flow diagram of studies identified in the meta-analysis
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was 55.5% (95% CI 48.9-62.1). Meta-analysis comparing the successful localization of 
the bleeding source in each study revealed that the pooled odds ratio for the diagnostic 
yield for CE compared to DBE was 1.39 (95% CI 0.88, 2.20; p=0.16) (Figure 2). Visual 
inspection of funnel plots revealed no evidence of publication bias.
Subgroup analysis of the diagnostic yield of DBE performed after a previously positive 
CE was calculated only from those studies that provided sufficient data (Table 2). Among 
these studies,14-17, 19, 20, 22 the pooled diagnostic yield was 75.0% (95% CI 60.1-90.0) and 
the odds ratio for the yield of DBE performed after a previously positive CE compared 
to that of DBE performed in all patients was 1.79 (95% CI 1.09-2.96; p=0.02) (Figure 3). A 
separate subgroup analysis revealed that the pooled diagnostic yield of DBE performed 
after a previously negative CE was 27.5% (95% CI 16.7-37.8).
Table 1. Summary of studies included in meta-analysis
Study Country Design Total patients OGIB patients 
examined with
CE and DBE
Study quality
(mean STARD score)
Matsumoto 
2005
Japan Prospective, 
blinded
13 13 Good
(15.5)
Hadithi 2006 Netherlands Prospective 
nonblinded
35 35 Excellent
(18)
Mehdizadeh 
2006
U.S.A. Retrospective, 
nonblinded
188 115 Moderate
(10)
Nakamura 
2006
Japan Prospective, 
blinded
32 28 Excellent
(17.5)
Fujimori 2007 Japan Prospective, 
nonblinded
45 45, 36† Good
(14.5)
Ohmiya 2007 Japan Retrospective, 
nonblinded
479 74 Good
(14.5)
Kameda 2008 Japan Prospective, 
blinded
32 32 Good
(16)
Arakawa 2009 Japan Retrospective, 
nonblinded
162 74 Excellent
(17)
Fukumoto 
2009
Japan Prospective, 
nonblinded
76 42‡ Excellent
(17.5)
Marmo 2009 Italy Prospective, 
nonblinded
193 193 Excellent
(20)
OGIB obscure GI bleeding, CE capsule endoscopy, DBE double balloon enteroscopy, STARD STandards for 
the Reporting of Diagnostic accuracy studies
†45 patients had CE but only 36 patients underwent DBE in the study by Fujimori et al.
‡Unpublished data from subgroup of patients with OGIB, provided by personal communication with study 
author Akira Fukumoto, MD PhD, Onomichi, Japan
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Table 2. Summary of diagnostic yields
Study n Positive 
CE
Positive 
DBE
Reclassify 
Positive CE
Reclassify 
Positive DBE
DBE yield 
after prior (+)
ve CE
DBE yield 
after prior (-)
ve CE
Matsumoto 
2005
13 10
(76.9%)
6
(53.8%)
8
(61.5%)
5
(38.5%)
- -
Hadithi 2006 35 28
(80%)
21
(60%)
- - 20/28
(71.4%)
1/7
(14.3%)
Mehdizadeh 
2006
115 63
(54.8%)
57
(49.6%)
- - 41/63
(65.1%)
16/52
(30.8%)
Nakamura 
2006
28 17
(60.7%)
12
(42.9%)
14
(50%)
12
(42.9%)
9/17
(52.9%)
3/11
(27.3%)
Fujimori 2007 45 
(36†)
18
(40%)
18
(50%)
18
(40%)
23
(63.9%)
16/16
(100%)
2/20
(10%)
Ohmiya 2007 74 37
(50%)
39
(52.7%)
48
(64.9%)
39
(52.7%)
- -
Kameda 2008 32 23
(71.9%)
21
(65.6%)
29
(90.6%)
21
(65.6%)
15/23
(65.2%)
2/3
(66.7%)
Arakawa 2009 74 40
(54.1%)
74
(63.5%)
- - 36/40
(90%)
11/34
(32.4%)
Fukumoto 
2009‡
42 16
(38.1%)
18
(42.9%)
- - - -
Marmo 2009 193 174
(90.2%)
132
(68.4%)
174
(90.2%)
132
(68.4%)
124/174
(71.3%)
8/19
(42.1%)
CE capsule endoscopy, DBE double balloon enteroscopy
†45 patients had CE but only 36 patients underwent DBE in the study by Fujimori et al.
‡Unpublished data from subgroup of patients with OGIB, provided by personal communication with study 
author Akira Fukumoto, MD PhD, Onomichi, Japan
- fields left blank where reclassification or subgroup results could not be discerned from the data
Figure 2. Relative diagnostic yield of CE compared to DBE
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DISCUSSION
Two previous meta-analyses7, 8 performed prior to our study both found similar diag-
nostic yields between CE and DBE (overall yield 60% for CE, 57% for DBE;7 odds ratio 
1.21 [95% CI: 0.64-2.29]8). However, these studies were not restricted to patients with 
OGIB, relied primarily on data presented in abstract form, and involved a relatively small 
numbers of subjects: 375 patients in the study by Pasha et al.7 and 277 in that by Chen et 
al.5 Our updated meta-analysis focused exclusively on patients with OGIB, and examined 
ten published studies involving 651 patients. However, despite the increased sample 
size, no statistically significant difference in diagnostic yield was found when CE and DBE 
were compared: 62% for CE and 56% for DBE, giving a non-significant odds ratio of 1.39 
for identifying the source of bleeding.
Despite the focus on OGIB patients unique to this study, our results replicated those of 
the previous meta-analyses.7, 8 Nevertheless, an interesting new finding from our study is 
the subgroup analysis revealing that the diagnostic yield of DBE performed after a previ-
ously positive CE is 75%, notably higher than the diagnostic yield of 56% when DBE is 
performed in all patients, giving a statistically significant odds ratio of 1.79. Similar results 
were obtained in the four studies that were identified by our search for this systematic 
review but were excluded from the meta-analysis because DBE was only performed in pa-
tients with a previously positive CE.24-27 The pooled diagnostic yield for DBE in these four 
studies was 81.1% (95% CI 75.1-87.1), Together, these data suggest that the yield from 
DBE is considerably enhanced when directed by findings from prior capsule endoscopy, 
an intuitive observation but one that has not been formally characterized previously.
A limitation of this comparative analysis is that in most studies, CE was performed prior 
to DBE and the endoscopist performing DBE was not blinded to the CE results. Since 
Figure 3. Increased diagnostic yield of DBE performed after positive CE
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there is a significantly increased diagnostic yield when DBE is performed after a positive 
CE, having the results from capsule endoscopy available may create detection bias in 
the yield of DBE. Only the studies by Nakamura et al.14 and Kameda et al.16 blinded the 
DBE endoscopist to the results of CE, and one study performed DBE prior to CE, which 
in effect is equivalent to blinding.18 The combined diagnostic yields from these studies 
showed a non-significant difference in favor of CE: 69.2% (95% CI 58.7-79.7) for CE and 
52.9% (95% CI 37.3-68.4) for DBE, (p=0.06) However, the combined sample size to make 
this comparison was small (n=73).
A further limitation of this meta-analysis is that the included studies examined 
patients both with overt OGIB and with occult OGIB and did not separately report 
results for these different groups. In fact, only two studies14,  18 involving a total of 45 
patients focused exclusively on overt OGIB, too small a number from which to draw any 
meaningful conclusions. It is very likely that patients with overt bleeding signs such as 
hematochezia or melena should be evaluated differently than patients with occult OGIB 
who present with fecal occult blood positivity or iron deficiency anemia. Indeed, a small 
retrospective case series by Mönkemüller et al.28 that examined the use of emergency 
DBE (defined as performance within 24 hours of clinical presentation) for overt obscure 
GI bleeding patients demonstrated the feasibility of such an approach. In this study, the 
putative bleeding source was identified, and endoscopic therapy applied, in nine out of 
ten patients during 17 emergency DBE procedures performed following negative gas-
troscopy and colonoscopy. Furthermore, it is already known that the diagnostic yields 
of both CE29-31 and DBE32 are highest when performed within a short interval of an overt 
bleeding episode. What remains unanswered by the existing literature and could not be 
addressed by this meta-analysis, are the comparative yields of CE and DBE specifically 
within this overt bleeding population, and whether the prior performance of CE leads 
to any clinically meaningful subsequent increased yield of DBE after overt bleeding, as 
our study has shown it to do within a mixed group that included both occult and overt 
OGIB patients.
In summary, the results from this meta-analysis demonstrate that CE and DBE have 
similar diagnostic yields for the evaluation of obscure GI bleeding, albeit within a cohort 
that included both occult and overt OGIB patients. This confirms that the diagnostic 
algorithm for OGIB should in most cases begin with CE, especially among patients 
with occult bleeding, in particular because of the relatively non-invasive nature of CE 
in comparison to enteroscopy and because the yield of DBE is significantly enhanced 
when guided by a previously positive capsule study. However, the best strategy for the 
evaluation of overt OGIB patients remains unanswered and further prospective studies 
are needed to compare CE and DBE in this group.
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ABSTRACT
Objective: Retrograde double balloon enteroscopy (DBE) is important for evaluating 
the distal small bowel but is more challenging compared to the oral route. Optimizing 
small bowel insertion may enhance the diagnostic utility of the examination. We sought 
to determine if insertion depths achieved with retrograde DBE when performed as an 
isolated procedure differed significantly from when performed immediately following 
anterograde DBE.
Materials and Methods: A retrospective analysis was conducted of all retrograde DBE 
procedures performed at our center with comparisons made between ‘distal-only’ DBE 
without preceding anterograde DBE, and ‘combined’ DBE after a prior same day antero-
grade DBE.
Results: Two hundred ninety retrograde DBE procedures were performed in 264 
patients over 5 years. Success of terminal ileal intubation exceeded 95%. The mean 
insertion depth into the distal small bowel differed significantly with 112 cm (95% CI 
95-129) in the ‘distal-only’ group and 92 cm (95% CI 85-98) in the ‘combined’ group 
(p=0.01), with a trend toward a corresponding increased diagnostic yield of 48% vs. 37% 
respectively (p=0.15). Multivariate regression analysis identified both insertion route 
strategy (‘distal-only’ > ‘combined’; p=0.01) and type of DBE endoscope (diagnostic > 
therapeutic; p=0.02) as significant predictors of retrograde insertion depth.
Conclusions: The insertion depth of retrograde DBE is significantly greater when carried 
out as a separate distal procedure and not in combination with a preceding anterograde 
DBE, and when performed using a diagnostic as opposed to the therapeutic DBE endo-
scope. This increased retrograde depth of insertion may be associated with an increased 
diagnostic yield.
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INTRODUCTION
The introduction of double balloon enteroscopy (DBE) over the past decade revolution-
ized our ability to visualize, sample histology, and provide therapeutics in the small 
bowel. While complete visualization of the small intestine is desirable, it is infrequently 
achieved in most centers with some exceptions(1, 2) and is most often not clinically 
necessary.(3) Nevertheless, optimizing the depths of the small bowel explored by DBE 
correlates with an increased frequency of identified abnormalities(4) and is important 
both to detect the presence and to confirm the absence of important pathology. The 
most commonly used approach is the combination of an anterograde procedure via 
the mouth, followed by a retrograde procedure via the anus if complete small bowel 
visualization is not achieved. The actual timing of this retrograde procedure is not well 
established: in some centers the retrograde procedure is performed at another sched-
uled appointment, while others perform a retrograde procedure immediately following 
the incomplete anterograde one.
Retrograde DBE enables the inspection of the distal small intestine and is usually in-
dicated when small bowel disease is suspected but anterograde DBE fails to identify 
responsible pathology, when capsule endoscopy or radiographic imaging suggests the 
presence of distal small bowel abnormalities,(5, 6) and when Crohn’s disease patients 
require evaluation beyond conventional ileo-colonoscopy.(7) However, the retrograde 
procedure is recognized as more technically challenging, with failure of terminal ileum 
(TI) intubation occurring in up to 21% of DBE cases.(8) Furthermore, once stable ileal 
intubation is achieved, depths of insertion from retrograde DBE and single balloon en-
teroscopy (SBE) are consistently much less than those achieved with anterograde DBE 
and SBE, ranging from 124 – 199 cm and 220 – 360 cm respectively.(9-15) Thus, identify-
ing factors that may improve the insertion depth of retrograde DBE is important. One of 
the factors that may influence the performance of retrograde DBE is the timing of the 
procedure. Combining anterograde and retrograde DBE into a joint same-day procedure 
may be of increased efficiency for patients who only have to undergo a single bowel 
preparation and make only one hospital visit, and for the physician who can complete 
the endoscopic evaluation more immediately. However, we suspect that combining the 
procedure may compromise the insertion depth of the retrograde DBE, possibly be-
cause of air insufflation during the anterograde portion or because of increased patient 
intolerance during the longer combined procedure.
The aim of this study was to determine if the depth of insertion of retrograde DBE was 
significantly affected by whether the distal procedure was performed by itself or in 
combination with a preceding anterograde DBE on the same day.
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METHODS
A retrospective analysis was performed of all retrograde DBE procedures performed at 
Erasmus MC University Medical Center, a tertiary referral university hospital in Rotterdam, 
The Netherlands. Procedure-related data were collected in a standardized, prospective 
fashion. All retrograde procedures were included in the analysis regardless of the indica-
tion for the investigation. SBE and spiral enteroscopy were excluded due to relatively 
low procedure numbers in comparison to DBE. The procedures were performed by three 
endoscopists with extensive accumulated experience in DBE, with the assistance of a 
trained enteroscopy nurse.
Double balloon enteroscopy procedure
DBE was performed with the Fujinon double-balloon enteroscopy system (Fujinon Inc., 
Saitama, Japan) using the diagnostic EN-450P5 endoscope prior to December 2006 and 
both the diagnostic and therapeutic EN-450T5 DBE endoscopes as clinically indicated 
after December 2006. DBE was performed according to the standard technique as de-
scribed by Yamamoto et al.(1) All patients received a standardized bowel preparation 
consisting of 4 L of a polyethylene glycol solution the evening prior to the procedure and 
an overnight fast from midnight. Conscious sedation was used in the majority of proce-
dures, using a combination of midazolam and fentanyl intravenously. In selected cases 
propofol sedation or general anaesthesia was administered. All cases were performed 
using standard air insufflation until September 2009, after which CO2 insufflation was 
used instead. Fluoroscopy was not routinely used to assist any of the DBE procedures 
except in selected cases (i.e. for dilation of stenotic lesions).
The clinical algorithm at our institution for patients with suspected small bowel 
pathology was to begin with an anterograde DBE. When the anterograde DBE provided 
a diagnosis that was sufficient explanation for the patient’s presentation, no subsequent 
retrograde DBE was performed unless clinically required. However, when the antero-
grade DBE was non-diagnostic or if the abnormalities identified were thought to be 
too minor to account for the patient’s symptoms, a subsequent retrograde DBE was 
performed, either on the same day immediately following the anterograde procedure 
or at a later date. The exception was Crohn’s disease patients undergoing enteroscopy 
to evaluate the extent of disease involvement or to assess disease activity, in whom 
bi-directional DBE was routinely performed.
Part of the reasoning behind our policy for a same day combined oral/anal DBE proce-
dure was that our hospital is a referral center for a significant portion of The Netherlands, 
with many patients having to travel from other cities to come for their small bowel 
investigations.
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‘Combined’ or ‘distal-only’ procedure
The retrograde DBE procedures were classified as ‘distal-only’ when performed in 
isolation without a preceding anterograde procedure. In contrast, when a retrograde 
procedure was performed following a prior anterograde DBE on the same day, it was 
classified as a ‘combined’ case. Clinical and demographic data were identified and en-
doscopic outcomes determined for all patients who underwent a retrograde DBE. The 
primary outcome of interest was the depth of insertion into the small bowel proximal 
to the ileocecal valve, as calculated using the standard method of counting push-and-
pull insertion cycles minus any endoscope slippage to estimate insertion depth.(16) 
Secondary outcomes included the diagnostic yield of the retrograde DBE procedures 
as well as subgroup analyses. For ‘combined’ cases the diagnostic yield was only calcu-
lated based on the results of the retrograde procedure and did not include any findings 
from the preceding anterograde DBE. Also, abnormalities identified in the colon during 
retrograde DBE were, for the purposes of this study, not considered positive findings 
contributing to the diagnostic yield of the enteroscopy, which was exclusively based on 
the diagnosis of small bowel lesions.
Statistical Analysis
The statistical software Stata 10.1 (Stata Corp, College Station, Texas) was used to analyze 
the data. Means and ranges were used to summarize data for continuous variables and 
percentages were used to summarize data for categorical variables. Student’s t-test was 
used to compare the primary outcome of the retrograde depth of insertion for ‘distal-
only’ DBE with that for ‘combined’ DBE. The Chi2 test was used to compare proportions for 
categorical variables, including the secondary outcome of diagnostic yield. Two-sided 
p-values were used at 80% power to define a statistically significant result with a p ≤ 
0.05. Univariate and multivariate regression analysis was then performed using ANOVA 
to identify variables that may have been predictive of the primary outcome of small 
bowel insertion depth.
RESULTS
During the study period between July 2004 and January 2010, 290 retrograde DBE 
procedures were performed in 267 patients, including 140 (52%) females, mean age 
47 (11 – 86) years. The most common indications for retrograde DBE were the evalu-
ation of Crohn’s disease (34%), iron-deficiency anemia or obscure GI bleeding (29%), 
and obstructive symptoms or abdominal pain (18%). Most retrograde DBE procedures 
were done as part of a ‘combined’ case (78%), whereas a minority were ‘distal-only’ 
cases (22%). Two-thirds of procedures were performed using the diagnostic EN-450P5 
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endoscope and one-third were performed with the therapeutic EN-450T5 endoscope. 
No significant differences in clinical features existed between patients in the ‘combined’ 
route group and patients in the ‘distal-only’ route group; see Table 1.
Conscious sedation was used in the majority of procedures: in 91% of ‘combined’ cases 
and 92% of ‘distal-only’ cases. Propofol was used for 8 (4%) procedures in the ‘combined’ 
group and for 5 (8%) procedures in the ‘distal-only’ group, whereas general anaesthesia 
was used in 12 (5%) cases in the ‘combined’ group and zero cases in the ‘distal-only’ 
group. Insufflation was achieved by using room air in 95% of retrograde DBE procedures 
since we have only recently adopted the use of CO2.
The success of terminal ileal intubation exceeded 95% and did not differ between the 
‘combined’ and ‘distal-only’ groups. There was a significant difference in the primary 
endpoint of the depth of insertion into the distal small bowel between the two groups, 
with a mean insertion of 92 cm (95% CI 85 – 98) in the ‘combined’ group and of 112 
cm (95% CI 95 - 129) in the ‘distal-only’ group (p=0.01). This corresponded to a trend 
toward an increased diagnostic yield of 48% in the ‘distal-only’ group compared to 37% 
in the ‘combined’ group that failed to reach statistical significance (p=0.15). There was a 
statistically significant increase in insertion depth in the ‘distal-only’ cohort compared to 
the ‘combined’ cohort for the anemia indication subgroup, for the non-Crohn’s disease 
Table I. Clinical features
Entire cohort Combined route Distal-only route p-value
Number (n) 290 227 (78.3%) 63 (21.7%)
Sex
Male 142 (49.0%) 115 (50.7%) 27 (42.9%)
Female 148 (51.0%) 112 (49.3%) 36 (57.1%) 0.27
Age (mean yrs; range) 46.7 (11-86) 47.2 (11-86) 44.9 (18-83) 0.35
Indications
Anemia 85 (29.3%) 63 (27.8%) 22 (34.9%) 0.27
Crohn’s disease 98 (33.8%) 79 (34.8%) 19 (30.2%) 0.49
Suspected Crohn’s 12 (4.1%) 11 (4.9%) 1 (1.6%) 0.25
Abdominal complaints∞ 53 (18.3%) 40 (17.6%) 13 (20.6%) 0.58
Chronic diarrhea 21 (7.2%) 17 (7.5%) 4 (6.4%) 0.76
Other§ 21 (7.2%) 17 (7.5%) 4 (6.4%) 0.76
Endoscopic DBE Modality
Diagnostic endoscope 194 (66.9%) 156 (68.7%) 38 (60.3%) 0.21
Therapeutic endoscope 96 (33.1%) 71 (31.3%) 25 (39.7%) 0.21
∞ Obstructive symptoms or abdominal pain
§ Includes refractory Celiac (n=2); Behcet’s disease (n=11); Peutz-Jeghers (n=6); Capsule retention (n=2)
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indication subgroup, and for procedures performed using the therapeutic DBE endo-
scope (see Table 2 for a summary of the endoscopic outcomes).
The mean total procedure time (exclusive of endoscope set-up time) was 82 (range 30 – 
155) minutes for the ‘combined’ group and 59 (range 30 – 100) minutes for the ‘distal-only’ 
group. Unfortunately, this procedure time for the ‘combined’ group includes both the 
anterograde and retrograde procedures, as these were not separately recorded. The pres-
ence of positive findings on the preceding anterograde procedure did not influence the 
time spent on the retrograde portion, as the mean ‘combined’ total procedure times was 
79 (95% CI 72.5 – 85.2) minutes when the anterograde DBE had yielded positive findings 
and was 83 (79.9 – 86.3) minutes when the anterograde DBE had been negative (p=0.26).
Table II. Endoscopic outcomes
Entire cohort Combined route Distal only p-value
Procedures (n) 290 227 63
Terminal ileum intubation (%) 277/290
(95.5%)
218/227
(96.0%)
59/63
(93.7%)
0.42
Mean depth of insertion into 
terminal ileum (95% CI; cm)
95.9
(89.5-102.4)
91.6
(84.8-98.3)
112.0
(95.2-128.9)
0.01
Diagnostic yield (%)
(95% CI)
39.4%
(33.6-45.1)
37.2%
(30.7-43.6)
47.5%
(34.7-60.2)
0.15
Indication
Established CD (n) 98 79 19
Insertion depth
(95% CI; cm)
79.3
(70.2-88.5)
76.4
(66.4-86.4)
92.4
(68.2-116.5)
0.18
Diagnostic yield 54.3%
(50/92)
54.7%
(41/75)
52.9%
(9/17)
0.90
Anemia (n) 85 63 22
Insertion depth
(95% CI; cm)
103.0
(90.5-115.6)
94.4
(81.0-107.8)
130.0
(100.7-159.3)
0.01
Diagnostic yield 28.0%
(23/82)
22.6%
(14/62)
45.0%
(9/20)
0.05
Endoscope
Diagnostic DBE (n) 194 156 38
Insertion depth
(95% CI; cm)
102.2
(94.3-110.1)
98.9
(90.8-107.0)
116.3
(92.3-140.2)
0.09
Diagnostic yield 34.7%
(66/190)
31.8%
(49/154)
47.2%
(17/36)
0.08
Therapeutic DBE (n) 96 71 25
Insertion depth
(95% CI; cm)
82.2
(71.6-92.9)
73.9
(62.5-85.3)
105.4
(81.6-129.3)
0.01
Diagnostic yield 49.4%
(43/87)
50.0%
(32/64)
47.8%
(11/23)
0.86
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Simple linear regression and multiple regression methods were used to identify vari-
ables that were predictive of the primary outcome of small bowel insertion depth. On 
univariate analysis, the significant variables were the route of insertion (i.e. ‘combined’ 
route or ‘distal-only’ route) (p=0.01), the type of endoscope (p=0.005), and the indica-
tion for the examination (p=0.007). The age or sex of the patient and the use of CO2 for 
insufflation did not significantly affect the insertion depth outcome. With multivariate 
regression, only the route of insertion and the type of endoscope remained significant, 
with the ‘distal-only’ group having insertion depths 21 cm (95% CI 6 - 36) further on 
average than the ‘combined’ group (p=0.008), and the diagnostic DBE endoscope 17 cm 
(95% CI 3 - 30) greater on average than the therapeutic DBE endoscope (p=0.02), after 
controlling for the other variables.
The most common endoscopic findings were ulcerative, inflammatory lesions found in 
29% of procedures, followed by vascular lesions (such as angiodysplasia) in 3%, polyps in 
3%, and various other findings in 4% of cases. There were no statistically significant differ-
ences between the ‘combined’ or ‘distal-only’ groups with respect to the type of findings. 
Among patients who underwent retrograde DBE for the assessment of anemia, 28% had 
positive findings, including 15% with ulcerative, inflammatory lesions, 5% with vascular 
lesions, 1% with polyps, and 7% with other findings; overall this includes 9 ‘distal-only’ 
procedures with positive findings (4 ulcers, 3 vascular, 2 other) and 14 ‘combined’ proce-
dures with positive findings (8 ulcers, 1 vascular, 1 polyp, 1 Meckel’s diverticulum, 3 other). 
Again, there were no significant differences between the ‘combined’ or ‘distal-only’ groups.
The rate of total enteroscopy with complete visual inspection of the small bowel was 
11% among the ‘combined’ group and 2% for the ‘distal-only’ group, but the latter only 
considered the retrograde DBE procedure by itself and not in combination with the pre-
viously performed anterograde DBE. This is because we tended to not make permanent 
ink markings of the most distal point reached during anterograde insertion, but rather 
used metal clips or took biopsies to create mucosal injury that would be recognized 
during an immediate retrograde procedure but would typically not be identifiable when 
the retrograde DBE was performed at a later date.
Three major complications (1%) occurred among our cohort: one episode of pancreatitis 
and two small bowel perforations. The acute pancreatitis occurred after a combined an-
terograde/retrograde procedure, but the patient recovered after conservative therapy 
during a short hospital stay. Both cases of perforation occurred after endoscopic balloon 
dilation of small bowel strictures (one radiation-induced, one Crohn’s disease) during 
the retrograde procedure. Both perforation patients went to surgery and recovered well 
post-operatively.
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DISCUSSION
While considerable research has been published describing the performance charac-
teristics of DBE, very little attention has been directed specifically to the retrograde 
procedure. To our knowledge, this is only the second study to have this focus and 
represents the largest cohort of retrograde DBE procedures yet described. This study 
demonstrates that for patients undergoing retrograde DBE at our center, insertion 
depths into the distal small bowel were significantly greater when the procedure was 
performed in isolation rather than in combination with a preceding anterograde DBE 
on the same day. This superior insertion depth corresponded to a non-significant trend 
toward a superior diagnostic yield with retrograde DBE in patients who only had the 
retrograde procedure. Furthermore, multivariate analysis demonstrated that in addition 
to the route of insertion strategy, the type of DBE endoscope used significantly affected 
the depth of insertion into the small bowel, favoring the diagnostic over the therapeutic 
DBE endoscope. Conversely, success of terminal ileal intubation seemed unaffected by 
the route of insertion or the type of endoscope, with excellent intubation rates (≥ 94%) 
in all subgroups of our cohort.
While the depth of insertion for retrograde DBE was significantly greater with the ‘distal-
only’ procedure compared to that with the ‘combined’ procedure, the insertion depths 
themselves achieved in this cohort, i.e. an overall mean insertion of 96 cm, appear infe-
rior to those that have been reported in the literature. Indeed, early DBE case-series that 
included both anterograde and retrograde DBE outcomes reported superior insertion 
depths from the retrograde procedure, ranging from 120 - 130 cm by the Wiesbaden 
group (n=122),(3, 9) to 182 cm by early U.S. expert centers (albeit in a cohort in which 
intubation of the TI failed in over 30% of cases; n = 77),(12) to advancement to “one-third 
to two-thirds of the length of the entire small intestine” with no failures of TI intuba-
tion by Yamamoto et al. (n=89)(1) In contrast, more recent reports from experienced 
endoscopy centers in Indianapolis (n=31) and Mayo Jacksonville (n=85) report more 
similar retrograde insertion depths of 116 cm and 124 cm respectively.(13, 17) The cause 
of this variability in retrograde insertion depths remains unclear. The imprecise nature 
of the method for the estimation of insertion depth may be partly responsible, which 
remains based on a subjective assessment by the endoscopist. Comparisons of reported 
insertion depths between institutions should therefore be interpretated with caution. 
Furthermore, there may be other variables involved, including factors relating to en-
doscopist experience, patient population factors, or procedural factors such as those 
identified in this study. Indeed, in the only other published study focusing on retrograde 
DBE (n=59), increased balloon enteroscopy experience was associated with superior 
TI intubation rates and increasing depths of small bowel insertion, with the learning 
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curve improving after 20 distal procedures.(8) However, lack of experience would not 
account for the inferior insertion depths achieved in our cohort as the DBE procedures 
were performed by 3 endoscopists with considerable enteroscopy experience. The small 
number of endoscopists performing the procedures in our cohort also strengthens the 
internal validity of our insertion depth estimation technique. A notable patient popula-
tion factor that may have had a negative impact on the depth of insertion is the high 
proportion of our cohort with Crohn’s disease (34%), which is a feature unique to our 
small bowel endoscopy population. The mean insertion depth for Crohn’s patients was 
79 cm, significantly less than the mean insertion of 104 cm for the rest of the cohort 
(p<0.001). That said, indication for the DBE was not an overall predictor of insertion 
depth in the multivariate analysis, and the apparent difference described above may 
in fact be due to confounding by route of insertion or type of endoscope. Furthermore, 
even when the Crohn’s patients are removed from our analysis, the depth of insertion 
among the remaining patients (104 cm) remains notably less than previous reports.
Another apparent discrepancy between this study and the existing literature is the 
relatively lower overall diagnostic yield of 39%. In contrast, in a meta-analysis that com-
pared DBE with capsule endoscopy, the pooled diagnostic yield for DBE was 57%.(18) 
However, the diagnostic yields for the studies included in this meta-analysis and nearly 
all the case-series reported in the literature consist of findings from the combination of 
both the anterograde and retrograde DBE procedures. In this study, the diagnostic yield 
was only determined from the small bowel findings identified during the retrograde 
procedure, regardless of what may have been identified by a previous anterograde ex-
amination. This means that our diagnostic yield of 39% actually represents the additive 
diagnostic value of performing the distal procedure, which would likely be of clinical 
relevance to many patients. In comparison, the only other study to describe outcomes 
separately for retrograde DBE (n=59) had a diagnostic rate of 47%.(8) Additional pos-
sible reasons for why our rate remains lower is that colonic findings did not contribute to 
the diagnostic yield in our study, whereas it has been shown previously that nearly 10% 
of abnormal findings detected by DBE in the work-up of OGIB are found in the colon.
(19) Finally, we do not perform capsule endoscopy at our centre, and as such, this was an 
unselected population less likely to have abnormalities than a pre-selected cohort with 
abnormal capsule findings.
What remains to be explained is why the insertion depth with retrograde DBE was 
significantly greater when performed as an isolated procedure as in the ‘distal-only’ 
group compared to when performed in conjunction with an immediately preceding 
anterograde DBE as in the ‘combined’ group. It is likely that air insufflation during the 
anterograde procedure plays a major role by distending the small bowel lumen and 
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thereby compromising the ability of the balloons to grip the intestinal wall. However, 
it is interesting that the use of CO2, which would be expected to overcome this factor, 
was not associated with greater insertion depths in the multivariate analysis, although 
perhaps the number of CO2 cases was insufficient to have enough statistical power to il-
lustrate a difference. Endoscopist fatigue would not be a confounding factor as our total 
procedure times are relatively short, nor would there be a greater inclination for the 
endoscopist to prematurely stop the retrograde DBE in ‘combined’ cases because of the 
presence of sufficient explanatory findings on the anterograde procedure, as our clini-
cal protocol dictated that we only proceeded to retrograde DBE when the anterograde 
portion was negative or yielded insufficient findings. However, it is possible that the 
endoscopist was more likely to terminate the retrograde procedure during ‘combined’ 
cases because of increasing patient intolerance caused by the increased duration of the 
‘combined’ procedure in the setting of conscious sedation, which was used in over 95% 
of cases. Indeed, the total procedure time for both anterograde and retrograde DBE in 
‘combined’ cases was 82 minutes compared to 59 minutes for ‘distal-only’ retrograde 
procedures. This suggests that the time devoted to the retrograde DBE during combined 
cases was likely less than that in ‘distal-only’ cases. Unfortunately, the lack of separate 
recordings of the procedure times for the anterograde and retrograde portions of ‘com-
bined’ cases means that this question cannot be answered.
There are several additional limitations to this study, most notably its retrospective 
design and the absence from the database of potentially relevant variables that may 
have affected insertion depth such as abdominal surgical history.(8, 17)
In addition, the large proportion of our patients who underwent enteroscopy to evalu-
ate the extent or activity of Crohn’s disease may make this cohort a less representative 
example for comparison to other centers performing DBE. That being said, when the 
Crohn’s disease patients are removed from the analysis and the remaining cohort is as-
sessed separately (n=192), a similar pattern of findings was observed with significantly 
greater retrograde insertion depths of 120 cm (95% CI 98 – 142) in the ‘distal-only’ group 
compared to 100 cm (95% CI 81 – 108) in the ‘combined’ group (p=0.04), and a sig-
nificantly increased corresponding diagnostic yield of 45% compared to 28% (p=0.04) 
respectively. Thus, the large proportion of Crohn’s disease patients does not appear to 
alter the findings of this study.
In summary, our study shows that the insertion depth of retrograde DBE is significantly 
greater when carried out as a separate procedure and when performed using a diag-
nostic DBE endoscope. This increased retrograde depth of insertion tends to be associ-
ated with an increased overall diagnostic yield. Thus, we recommend that patients who 
require retrograde DBE have this done as a separate procedure and not on the same 
70 Chapter 5
day as a prior anterograde DBE, and suggest considering the use of a diagnostic rather 
than therapeutic DBE endoscope, unless the likelihood of therapeutic intervention is 
considered to be high.
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ABSTRACT
Aims: To determine the incidence of pancreatitis and hyperamylasemia with spiral 
enteroscopy.
Background: Acute pancreatitis is a significant potential complication with double bal-
loon enteroscopy (DBE). Hyperamylasemia is frequently observed after both DBE and 
single balloon enteroscopy (SBE) but often without associated pancreatitis. Whether the 
same phenomenon occurs with spiral enteroscopy is currently unknown.
Study methods: A prospective cohort study of consecutive patients undergoing 
proximal spiral enteroscopy was conducted. Serum amylase levels were measured im-
mediately before and following the procedure, combined with observation for clinical 
signs of pancreatitis.
Results: 32 patients underwent proximal spiral enteroscopy with a mean total pro-
cedure time of 51 minutes (range 30 – 100) and depth of insertion of 240 cm (range 
50 – 350). The diagnostic yield was 50%, with 31% of all procedures being therapeutic. 
While no patients exhibited signs that raised suspicion of pancreatitis, hyperamylasemia 
was common (20%). Hyperamylasemia was not significantly associated with procedure 
duration or depth of insertion but was linked to patients with Peutz-Jeghers syndrome 
and with the use of propofol sedation, suggesting that it may be more common in dif-
ficult cases.
Conclusions: Postprocedural hyperamylasemia occurs frequently with proximal spiral 
enteroscopy, while no associated pancreatitis was observed. This frequent finding sug-
gests that hyperamylasemia may not necessarily reflect pancreatic injury nor portend a 
risk of pancreatitis.
Hyperamylasemia and pancreatitis after spiral enteroscopy 75
6
INTRODUCTION
Spiral enteroscopy1, 2 is the latest form of small bowel endoscopy to join the techniques 
of single balloon enteroscopy (SBE)3 and double balloon enteroscopy (DBE)4, 5 for the 
investigation of small intestinal diseases. Large series have been performed with DBE 
demonstrating that the most common, significant adverse events with the procedure are 
bleeding (0.2-0.8%), perforation (0.3-0.4%) and pancreatitis (0.2-0.3%).6, 7 While consider-
able attention has focused on the occurrence of post-DBE pancreatitis, asymptomatic 
hyperamylasemia remains quite common.8 In the first study reporting complications 
with SBE, there were no cases of pancreatitis but again hyperamylasemia was frequently 
encountered.9 Currently, there are no published studies on complications with spiral 
enteroscopy, and the risks of pancreatitis and hyperamylasemia remain unknown. Thus, 
the aim of this study was to determine the incidence of pancreatitis and hyperamylas-
emia after proximal spiral enteroscopy.
MATERIALS AND METHODS
Study design
Consecutive patients undergoing proximal spiral enteroscopy at Erasmus MC University 
Medical Center, a tertiary referral university hospital in Rotterdam, The Netherlands, 
were prospectively included in the study after providing written informed consent. 
Demographic and clinical data were noted and the insertion depth, duration, seda-
tion requirements, diagnostic and therapeutic outcomes, and adverse events were 
recorded. Blood samples were collected immediately prior and 2 – 4 hours following 
the proximal spiral enteroscopy procedure for measurement of serum amylase and C-
reactive protein (CRP). All patients were clinically evaluated 2 – 5 hours after the proce-
dure to assess for abdominal complaints that could be suggestive of pancreatitis. Any 
need for overnight hospital stay or readmission was noted. All patients were contacted 
the following day for evaluation of complaints. Referring physicians and/or general 
physician were asked to report adverse outcomes within 30 days of the procedure. 
The study was approved by the institutional review board of Erasmus MC University 
Medical Center.
Spiral enteroscopy procedure
Spiral enteroscopy was performed using the Discovery SB spiral overtube (Spirus 
Medical Inc.; Stoughton, Mass) in combination with either the Olympus SIF-Q160Y SBE 
endoscope (Olympus Optical Co., Tokyo, Japan) or the Fujinon EN-450P5 or EN-450T5 
DBE endoscopes (Fujinon Inc., Saitama, Japan) without attached balloons. The spiral 
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overtube has raised helices at its distal end, a locking device to fix the overtube to the 
endoscope, and two foam handles at its proximal end to facilitate overtube rotation. 
Clockwise rotation of the spiral overtube acts in a similar manner to that of a screw, 
advancing the endoscope while pleating the bowel onto its surface.1 The procedure was 
performed by two physicians: an endoscopist with considerable small bowel enteros-
copy experience (P.M.) together with an advanced endoscopy fellow (C.T. or H.A). The 
endoscope was inserted into the proximal esophagus in the usual fashion, after which 
further advancement was achieved by rotation of the overtube by twisting of the foam 
handles. While the first operator rotated the overtube, the second operator steered the 
endoscope tip. Withdraw of the endoscope was achieved by counter-clockwise overtube 
rotation. The depth of insertion was estimated during endoscope withdrawal according 
to the previously described and accepted spiral enteroscopy method.1, 2
All patients had bowel preparation with 4 L of a polyethylene glycol solution and an 
overnight fast, which is the standard practice for small bowel enteroscopy at our institu-
tion due to our belief that improved mucosal views are obtained once deep insertion 
reaches the ileum. Most procedures were performed under conscious sedation (mid-
azolam and fentanyl) while selected cases were done using anesthesia-administered 
propofol. Propofol was selected for cases expected to be prolonged or more difficult 
(e.g. multiple polypectomies in Peutz-Jeghers patients), as well as for cases performed 
during live endoscopy courses. With few exceptions, spiral enteroscopy was performed 
without prior capsule endoscopy, which is not performed at our center, and was chosen 
in favor of DBE or SBE according to the endoscopist’s discretion. All procedures were 
performed on an outpatient basis.
Definition of hyperamylasemia and pancreatitis
Hyperamylasemia was defined as a twofold or greater increase in serum amylase (ratio 
of post-procedure to pre-procedure amylase ≥ 2) to a level exceeding the upper limit of 
normal (> 99 U/L). Clinical pancreatitis was defined according to the revised 2008 version 
of the Atlanta Classification of acute pancreatitis, which consists of typical abdominal 
pain strongly suggestive of acute pancreatitis, serum amylase at least three times greater 
than the upper limit of normal and/or characteristic findings of acute pancreatitis on 
contrast-enhanced CT scan.10 Radiological imaging was not routinely performed in all 
patients but instead was reserved for cases when pancreatitis was suspected based on 
clinical grounds (abdominal pain with abnormal amylase between 100-299 U/L that was 
less than 3 times the upper limit of normal). An abnormal pre-procedure serum amylase 
of ≥ 100 U/L in combination with the absence of postprocedural abdominal pain was 
considered sufficient to exclude pancreatitis and suggest macroamylasemia. The normal 
values for serum amylase and CRP were 0 – 99 U/L and < 9 mg/L, respectively.
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Statistical analysis
The statistical software Stata 10.1 (Stata Corp, College Station, Texas) was used to analyze 
the data. Means and ranges were used to summarize data for continuous variables and 
percentages were used to summarize data for categorical variables. Continuous data 
were compared using Student’s t-test (with Welch’s approximation to correct for unequal 
variances) while categorical data were assessed with the Chi-squared test. A two-sided 
p-value of < 0.05 was considered statistically significant. Univariate and multivariable 
logistic regression were planned but not performed because the number of positive 
outcomes was too low to draw reliable conclusions from that analysis.
RESULTS
Patient characteristics
Between November 2008 and March 2010, 32 patients underwent proximal spiral enter-
oscopy, with a mean age of 64 (range 32 – 86) years; 19 (59%) were females. The most 
common indications for small bowel enteroscopy were anemia (81%) and Peutz-Jeghers 
Table 1. Clinical and endoscopic data
Entire cohort (n=32)
Patient characteristics
Age, years (range) 64 (32 – 86)
Female sex 19 (59%)
Indication for enteroscopy
- anemia 26 (81%)
- Peutz-Jeghers 4 (13%)
- otherª 2 (6%)
Enteroscopy data
Conscious sedation 20 (63%)
Propofol sedation 12 (37%)
Insertion depth, cm (range) 240 (50-350)
Procedure time, min (range) 51 (30 – 100)
Diagnostic yield 16 (50%)
- angiodysplasia 7 (22%)
- polyp(s) 4 (13%)
- tumor 3 (9%)
- ulcer(s) 2 (6%)
Therapeuticsb 10 (31%)
ª Abdominal pain with abnormal imaging (n=2)
b Polypectomy (n=4; removed 24 polyps), argon plasma coagulation (n=6)
78 Chapter 6
syndrome (13%); see Table 1. Two patients with anemia had undergone prior video cap-
sule endoscopy, whereas two of the Peutz-Jeghers patients previously had DBE. None 
of the included patients had a medical history of acute or chronic pancreatitis. While 6 
(19%) patients consumed ≥ 2 units of alcohol per week, no patient consumed more than 
5 units.
Spiral enteroscopy procedure
The mean depth of insertion beyond the ligament of Treitz was 240 cm (range 50 - 350) 
with an average total procedure time of 51 (range 30 - 100) minutes. Conscious sedation 
was used for 20 (62%) while anesthesia-administered propofol was used in 12 (38%) 
patients. All Peutz-Jeghers syndrome patients received propofol, compared to 29% of 
the remaining cohort. The majority of patients (91%) underwent just the proximal pro-
cedure, with only 3 (9%) having both a proximal and a distal spiral enteroscopy. Among 
those 3 patients, total enteroscopy with complete visualization of the small bowel was 
not achieved. The proximal spiral enteroscopy was diagnostic in 50% of cases, identify-
ing angiodysplasia in 7 (22%), polyps in 4 (13%), a tumor in 3 (9%), and ulcerations in 2 
(6%) procedures. Spiral enteroscopy was therapeutic in 10 (31%) patients, with argon 
plasma coagulation used to treat angiodysplasia in 6 (19%) (performed when angiodys-
plasias were considered clinically significant, defined as “large” lesions or ones that bled 
when probed by a catheter) and polypectomy performed in 4 (13%) cases, removing a 
total of 24 polyps.
Hyperamylasemia and pancreatitis
Serum samples were taken at a mean of 175 (range 130 – 270) minutes after the spiral 
enteroscopy procedure. Two patients had an elevated amylase prior to the procedure, 
101 and 112 U/L respectively, without any signs or symptoms suggestive of pancreatitis. 
Neither of these patients developed an elevation in serum amylase after the procedure 
greater than two times the baseline value, rising to 112 and 167 U/L respectively. Both 
were considered to have macroamylasemia and were excluded from subsequent analy-
sis.
Six (19%) patients developed hyperamylasemia with a mean ratio of post- to pre-proce-
dure amylase of 2.9 and a mean post-procedure amylase level of 210 (range 104 – 510) 
U/L, reflecting an average increase in amylase of 139 (range 56 – 403) U/L. These changes 
significantly exceeded those among the 24 (80%) patients without hyperamylasemia, 
who had a mean post-procedure amylase of 73 U/L (p < 0.01) and an average increase of 
only 21 U/L (p < 0.01). The mean CRP levels did not increase after the spiral procedures 
and did not differ significantly between patients with normal amylase and those with 
hyperamylasemia. Comparing the patient group with post-procedural hyperamylasemia 
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with the normal amylase group, the only significant differences were the indication for 
the procedure (p=0.01) and the type of sedation used (p=0.01) (hyperamylasemia was 
more likely with Peutz Jeghers patients and propofol sedation; normal amylase levels 
were more likely with anemia as the indication and conscious sedation). There were no 
significant differences in terms of demographic features or endoscopic outcomes, in-
cluding both depth of insertion and procedure time (see Table 2). In addition, there was 
no significant linear relationship between the duration of the enteroscopy procedure 
and the subsequent change in serum amylase level (p=0.34).
There were no cases of acute pancreatitis. In fact, none of the patients experienced 
post-procedural abdominal pain that raised suspicion for possible pancreatitis and so 
no imaging studies were performed. Furthermore, no adverse events were recorded at 
follow-up.
Table 2. Comparison of normal amylase and hyperamylasemia groups
Normal amylase
(n=24)
Hyperamylasemia
(n=6)
p-value
Patient characteristics
Age, years (range) 65 (32 – 86) 60 (34 – 83) 0.59
Female sex 15 (63%) 3 (50%) 0.58
Indication (anemia) 22 (92%) 3 (50%) 0.01
Enteroscopy data
Conscious sedation 18 (75%) 1 (17%) 0.01
Propofol sedation 6 (25%) 5 (83%) 0.01
Insertion depth, cm (range) 233 (50 – 350) 250 (200 – 300) 0.43
Procedure time, min (range) 50 (30 – 100) 62 (30 – 80) 0.26
Diagnostic yield 11 (46%) 4 (67%) 0.36
Therapeutic yield 7 (29%) 3 (50%) 0.17
Serum measurements
Amylase (U/L) (all range)
Pre-procedure amylase 52 (28 – 98) 71 (27 – 113) 0.08
Post-procedure amylase 73 (28 – 130) 210 (104 – 510) <0.01
Absolute ∆ (Post – Pre) 21 (-3 – 44) 139 (56 – 403) <0.01
Ratio Post-amylase/pre-amylase 1.4 (0.9 – 2.3) 2.9 (2.0 – 4.8) <0.01
CRP (mg/L) (all range)
- pre-procedure 17 (1 – 190) 5 (1 – 16) 0.17
- post-procedure 17 (1 – 206) 6 (1 – 20) 0.23
Clinical pancreatitisa 0 0 -
Data presented with percentages unless otherwise stated.
a Defined according to the revised (2008) Atlanta Classification for acute pancreatitis.
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DISCUSSION
Acute pancreatitis is a concerning potential complication with DBE. Large, multicenter, 
retrospective studies suggested the risk of pancreatitis after diagnostic DBE procedures 
was 0.2-0.3%.6, 7, 11 Two prospective studies demonstrated a much higher frequency of 
hyperamylasemia (up to 50%) after DBE than the observed rate of pancreatitis (nearly 
5%).12,  13 This has been interpreted as evidence of a causative link between oral DBE, 
hyperamylasemia and pancreatic injury. However, multiple theories have been put 
forth speculating about the mechanism by which DBE leads to pancreatitis with no 
clear consensus.14 Recently, we performed two prospective studies with DBE8 and SBE9 
demonstrating that after modifying the insertion technique to delay balloon inflation 
until beyond the ligament of Treitz, the incidence of pancreatitis was very low; 0.7% 
and 0% for DBE and SBE respectively. However, hyperamylasemia remained relatively 
common, 17% and 16% for DBE and SBE respectively, although much less so compared 
to earlier reports.12, 13 It is unclear if this persistent hyperamylasemia results from injury 
to the pancreas or if it is caused by other factors, such as local strain or mucosal injury 
to the small bowel itself.
In this current study, 20% of patients developed hyperamylasemia after proximal spiral 
enteroscopy, with no patients developing suggestive abdominal pain symptoms and 
no cases of pancreatitis. Interestingly, the development of hyperamylasemia was not 
associated with the duration of the procedure as has been suggested by previous DBE 
studies.8, 13. However, the development of hyperamylasemia was significantly associated 
with Peutz-Jeghers syndrome and with propofol sedation. Since propofol was specifi-
cally selected for cases anticipated to be more technically challenging and since Peutz-
Jeghers patients each underwent multiple polypectomies (mean 6 polyps per patient), 
it is interesting to speculate that the development of hyperamylasemia may be more 
closely linked to difficult procedures, which may not necessarily be longer than other 
cases but may involve more strain on the pancreas or on the small bowel itself.
The present study has several limitations, chief among them its small sample size. We 
observed a high frequency of hyperamylasemia without associated pancreatitis, but the 
sample was insufficient to capture these events.
Indeed, only multicenter registry data are likely capable of identifying complications as 
infrequent as pancreatitis. In fact, a large, multicenter registry exists that has reported 
in abstract form the early experience with spiral enteroscopy, and found no cases of 
pancreatitis after 1750 spiral procedures.15 While amylase levels were not reported, the 
absence of pancreatitis after such a considerable number of procedures implies that the 
Hyperamylasemia and pancreatitis after spiral enteroscopy 81
6
risk is low with spiral enteroscopy, and suggests that the hyperamylasemia observed 
in our study is not necessarily a harbinger of pancreatitis. A second notable limitation 
is our lack of measurement of serum lipase or fractionation of pancreatic and salivary 
amylase isoenzymes, which may have been useful for differentiating the origin of the 
elevated amylase. Even though other series examining DBE and hyperamylasemia have 
shown a strong correlation between serum amylase and lipase measurements,12, 13 it is 
regrettable that these were not measured in our study to provide more definitive evi-
dence regarding the source of hyperamylasemia.
Nevertheless, the findings of this study begin to shed more light on the etiology of 
hyperamylasemia observed after deep enteroscopy. Since the spiral method does not 
involve the inflation of balloons nor the same degree of stretching of the small bowel 
with repetitive insertion and shortening of the endoscope and overtube, a number of 
previously considered causative theories seem less likely given the persistent observa-
tion of hyperamylasemia after spiral enteroscopy. In particular, duodenal hypertension 
from balloon inflation,16 mechanical strain on the pancreas from repetitive stretching of 
the endoscope and overtube,17-19 irritation of the pancreatic sphincter from the inflation 
of the overtube balloon or compression of the sphincter from the back-and-forth move-
ments of the overtube20 seem much less likely. However, the suggestion of mechanical 
strain on the pancreas from the profound straightening of the duodenum at the liga-
ment of Treitz,11 as well as the ischemic vascular injury theory due to compression or 
stretching of the peri-pancreatic vessels18, 20 remain. In addition, it is still possible that 
overtube-induced strain on the small bowel itself is responsible for the hyperamylas-
emia.21
In summary, this study is the first to report the incidence of hyperamylasemia after 
proximal spiral enteroscopy, being a frequent finding occurring after one-in-five proce-
dures despite no cases of pancreatitis. Thus, we hypothesize that while DBE can clearly 
cause pancreatitis, patients who develop elevated amylase levels after deep enteros-
copy do not necessarily have injury to the pancreas or elevated risk for pancreatitis. In 
fact, patients with significant abdominal pain after enteroscopy, even in the context of 
an elevated amylase, should first be evaluated for other, possibly more serious com-
plications such as intestinal perforation before considering pancreatitis, particularly in 
light of reports of perforations resulting from spiral enteroscopy,15, 22 and the growing 
realization that pancreatitis is an unlikely event for which hyperamylasemia may be a 
non-specific finding.
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The development of new techniques and technologies are necessary in order to con-
tinually advance the capabilities and performance of GI endoscopy. This is important 
because it may improve the medical care of patients with gastrointestinal ailments. To 
ensure that patient care benefits from innovations in endoscopy committed research 
efforts and ongoing, critical evaluations of current practices are required. In this thesis 
these issues were addressed with respect to colonoscopy and to small bowel endoscopy.
Magnetic imaging-assisted colonoscopy (MIC) is an innovative technology that utilizes 
electromagnetic coils embedded within the endoscope that are detected by an external 
receiver dish, resulting in the production of a three dimensional image of the shape of 
the endoscope while inside the patient’s body, which is then projected onto a display 
monitor. This enables the endoscopist to directly identify the position of the endoscope 
tip as well as to visualize any loop formation that may hinder the advancement of the 
colonoscope. The hope was that a newly redesigned, second generation MIC would 
result in faster and more successful colonoscopy on the part of the endoscopist and a 
more comfortable and safe procedure for patients. In a prospective clinical trial (Chapter 
2) in which patients were randomized to undergo MIC or conventional colonoscopy, no 
significant differences were observed in terms of procedural outcomes such as cecal 
intubation rate, time-to-cecum, endoscope insertion distance, or polyp detection rate, 
and no differences were seen with respect to patient comfort and sedation requirements, 
or with safety. Only amongst a subgroup of procedures self-rated by the endoscopist as 
difficult did any significant differences emerge, specifically with faster times-to-cecum 
for the MIC group. Nevertheless, the a priori hypothesis in this study was that MIC would 
improve technical performance and patient comfort for routine colonoscopy procedures 
in general, which is not supported by the findings. In fact, based on this study there ap-
pears to be little evidence to support the widespread, routine use of MIC, and certainly 
no justification to support the additional costs of adopting the technology. While there 
may exist an important role for using MIC for challenging or previously failed colonos-
copy cases, this remains an hypothesis derived from subgroup analysis and requires 
further study on its own. In addition, while there are many theoretical benefits for using 
MIC to facilitate colonoscopy training for GI residents and fellows,1 this question was not 
addressed by this study and so no conclusions can be drawn in this regard.
Despite various improvements in colonoscopy technology and technique, a proportion 
of procedures will invariably be incomplete, failing to successfully reach the cecum. This 
is a concerning problem, particularly in the context of colon cancer screening and polyp 
surveillance where complete colon examination is essential.2 In recent years, double 
balloon endoscopy (DBE) and single balloon endoscopy (SBE) emerged as effective new 
technologies for enteroscopy deep into the small bowel.3,4 In order to perform retro-
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grade balloon-assisted enteroscopy up from the distal ileum, the DBE or SBE endoscope 
must first be completely advanced through the colon. This led to the idea that DBE could 
be used as a salvage method to enable the completion of colonoscopy in cases that had 
previously failed by conventional means, a concept that has been successfully demon-
strated.5 In this paper, SBE has now been shown (Chapter 3) to also be a feasible and safe 
technique for patients with previously failed colonoscopy, achieving outcomes similar 
to those in earlier studies regarding DBE colonoscopy. Complete colonoscopy to the ce-
cum was achieved in 96% of cases using SBE, similar to completion rates of 88% - 100% 
seen with DBE.6-8 However, it must be noted that balloon-assisted colonoscopy, whether 
with SBE or with DBE, is a more time consuming and laborious procedure compared to 
standard colonoscopy, with median procedure times of 30 minutes in our study. Thus, 
while most patients who have an incomplete colonoscopy can be safely “rescued” by us-
ing SBE or DBE, it takes longer to complete these cases with balloon assistance, although 
without need for deep sedation, unlike when DBE or SBE are performed for enteroscopy 
deep into the small bowel.
In the next section of this thesis, attention shifted from colonoscopy to the new techniques 
of small bowel endoscopy, which predominantly consist of capsule endoscopy (CE) and 
DBE, but also include the newer methods of SBE and spiral enteroscopy. The most frequent 
indication for small bowel endoscopy is for the investigation of obscure GI bleeding (OGIB) 
after negative esophagogastroduodenoscopy (EGD) and colonoscopy indicate that a GI 
bleeding source may be located within the small bowel.9 In this paper, a meta-analysis 
was performed (Chapter 4) to determine whether a higher diagnostic yield is achieved by 
performing CE or DBE in these OGIB patients. The meta-analysis only included studies that 
had directly compared CE and DBE specifically for the evaluation of OGIB, and in this way 
differed from previous systematic comparisons of CE and DBE.10,11 The data showed that 
CE and DBE have similar diagnostic yields for OGIB, 62% and 56% respectively, with a non-
statistically significant higher odds ratio for CE compared to DBE of 1.39 (95% CI 0.88-2.20; 
p=0.16). Thus, both CE and DBE are equally likely to identify a bleeding source in patients 
with OGIB. However, two other important findings emerged from this study. The first was 
that the yield for DBE performed after a previously positive CE (75%) was substantially 
higher than that for DBE performed in all OGIB patients (p=0.02), and that the yield for DBE 
after a negative CE (28%) is much lower. While this makes intuitive sense, it provides fur-
ther rationale for the argument that in most patients, small bowel investigations for OGIB 
should begin with CE, since doing so optimizes the performance of the highly invasive and 
time consuming DBE procedure by selecting the patients most likely to benefit.
The second point was that DBE performed after a normal CE identified a bleeding source 
in more than one-fourth of patients. This means that when clinical suspicion remains 
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high or if bleeding reoccurs, further small bowel investigations should be considered 
even after a negative CE.
Optimizing the performance of retrograde DBE was the subject of the next section of 
this paper (Chapter 5). In particular, the technical performance of retrograde DBE was 
compared between combined bi-directional cases, in which the retrograde procedure 
immediately followed anterograde DBE, and uni-directional cases, in which retrograde 
DBE was performed solely on its own. The study demonstrated that significantly in-
creased endoscope insertion depth above the ileocecal valve was achieved when retro-
grade DBE was performed in isolation rather than as part of a combined procedure, with 
a trend toward a corresponding increase in diagnostic yield. Furthermore, regression 
analysis suggested that greater distal insertion was achieved when using the narrower 
caliber diagnostic rather than larger therapeutic endoscope. The results from this study 
provide useful information that may lead to more effective and efficient performance of 
distal DBE, suggesting that in most circumstances, retrograde DBE should be performed 
by itself as an isolated, uni-directional procedure rather than as part of a bi-directional 
procedure that follows anterograde DBE. Furthermore, when maximal insertion depth 
into the distal small bowel is desired and therapeutic interventions are considered 
unlikely, a diagnostic rather than a therapeutic enteroscope should be considered.
There is a relative paucity of data available for spiral enteroscopy, the newest version of 
overtube-assisted small bowel endoscopy. In fact, only a small number of studies have 
been published, contributing to a relatively limited understanding of endoscopic pro-
cedural outcomes, long-term clinical outcomes, and safety using this new endoscopic 
device. Thus, while many studies have characterized the adverse event profile associated 
with DBE,12-14 none have done the same for spiral enteroscopy. In particular, the risk of 
acute pancreatitis is well documented following DBE, as well as the much higher inci-
dence of significant elevation of serum amylase.15,16 The final study included in this paper 
examined the risk of acute pancreatitis and hyperamylasemia following anterograde 
spiral enteroscopy (Chapter 6). While no cases of acute pancreatitis were observed, the 
incidence of hyperamylasemia remained high at 20%. This mirrors the increasingly com-
mon observation that significant elevations of serum amylase occur with many forms 
of overtube-assisted small bowel endoscopy without associated pancreatitis,17 raising 
the possibility that hyperamylasemia in the context of small bowel endoscopy may not 
necessarily represent pancreatic injury nor portend risk for acute pancreatitis.
On other hand, it is equally possible that hyperamylasemia reflects subclinical pan-
creatitis, and so ongoing vigilance remains necessary regarding the possibility of this 
serious complication. While no case of acute pancreatitis following spiral enteroscopy 
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has been reported to date by this or by other studies, this may simply be a function of 
insufficient sample size. Only time will tell whether the different mechanism of insertion 
with spiral enteroscopy (rotation of raised helices on the overtube leading to progres-
sive movement) compared to that with DBE and SBE (push-and-pull cycles associated 
with successive inflation and deflation of balloons) is somehow protective against acute 
pancreatitis. This question is particularly difficult to answer since the mechanism of 
acute pancreatitis in DBE has never been clearly determined.18,19
GENERAL CONCLUSION
This thesis examined innovation and best practices in endoscopy, first with respect 
to colonoscopy, and second in regards to small bowel endoscopy. The findings from 
the included studies provide useful information that may help improve the practice 
of endoscopy. The thesis makes clear that critical evaluation of existing practices and 
scrutiny of new technologies is essential on a widespread scale and on an ongoing basis, 
in order to maximize the capabilities and performance of GI endoscopy. I hope that I 
may continue to contribute to these efforts throughout my career in Gastroenterology.
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